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No te rindas, aún estás a tiempo 
de alcanzar y comenzar de nuevo, 
aceptar tus sombras, 
enterrar tus miedos, 
liberar el lastre, 
retomar el vuelo. 
no te rindas que la vida es eso, 
continuar el viaje, 
perseguir tus sueños, 
destrabar el tiempo, 
correr los escombros, 
y destapar el cielo. 
no te rindas, por favor no cedas, 
aunque el frío queme, 
aunque el miedo muerda, 
aunque el sol se esconda, 
y se calle el viento, 
aún hay fuego en tu alma 
aún hay vida en tus sueños. 
porque la vida es tuya y tuyo también el deseo 
porque lo has querido y porque te quiero 
porque existe el vino y el amor, es cierto. 
porque no hay heridas que no cure el tiempo. 
abrir las puertas, 
quitar los cerrojos, 
abandonar las murallas que te protegieron, 
vivir la vida y aceptar el reto, 
recuperar la risa, 
ensayar un canto, 
bajar la guardia y extender las manos 
desplegar las alas 
e intentar de nuevo, 
celebrar la vida y retomar los cielos. 
no te rindas, por favor no cedas, 
aunque el frío queme, 
aunque el miedo muerda, 
aunque el sol se ponga y se calle el viento, 
aún hay fuego en tu alma, 
aún hay vida en tus sueños 
porque cada día es un comienzo nuevo, 
porque esta es la hora y el mejor momento. 




A mi padre que me enseñó el amor por la curiosidad matemática y 
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Stroke is a major public health concern in industrialized countries 
and the leading cause of disability worldwide: hence, after a stroke a 
large number of patients remain impaired, mainly for motor deficits [1].  
Motor recovery is typically incomplete [2]. After the episode, 60-
70% of stroke survivors can’t come back to their usual previous life, in 
terms of activities of daily living with their paretic hand [3].  
Nevertheless, stroke patients usually experience partial 
spontaneous functional recovery; this phenomenon could be due to the 
reorganization of remaining neural circuits with the final aim of 
redeveloping the superior control over the muscles deprived of their 
normal corticospinal inputs [4]. This reorganization represents the 
phenomenon of brain plasticity that could be defined as any enduring 
change in cortical properties. Plasticity is continuously modified by 
experience and learning and seems to be activated after brain lesions in 
order to regain a new functional homeostasis [4].  
In the last decades, plasticity of human brain has been studied in 
vivo by means of non-invasive brain stimulation (NIBS) techniques.  
NIBS allows not only functional evaluation of corticospinal 
pathways in clinical setting, specifically by means of single pulse 
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transcranial magnetic stimulation (TMS) [5], but also a measurement of 
excitatory and inhibitory phenomena due to activation of different neural 
elements in the stimulated area of the cortex [6-12]. 
Functional neuroimaging studies have demonstrated that 
recovered motor function in the paretic hand of chronic stroke patients 
relies predominantly on reorganized activity within motor areas of the 
affected hemisphere (AH) [13,14]. Furthermore, changes in gamma-
aminobutyric acid (GABA)-ergic activity in perilesional cortex after stroke 
seem to have a central role in recovery [15]. Furthermore, animal and in 
vitro models demonstrated that in the acute phase of a stroke various 
markers of plasticity are at higher levels both in perilesional territories of 
affected hemisphere  [16,17] and remotely in the contralateral unaffected 
hemisphere (UH) [18]: it could be reasonable that, during this phase, the 
effects of neurorehabilitation and neuromodulatory therapy might be 
maximized. 
The most influential model of stroke recovery is based on the 
inter-hemispheric rivalry or competition hypothesis: the AH becomes 
doubly disabled, both by its own damage and by the increased hindering 
output from UH, no longer inhibited by the hypo-functioning AH [2,19]. 
According to this model, increasing the cortical excitability on the 
affected side and/or reducing the excitability of the unaffected side can 
favor recovery. 
 
NIBS can modulate cerebral cortex excitability not invasively and 
seem to be a promising tool for driving plasticity in damaged brain [20].  
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The changes induced by NIBS, in form of repetitive transcranial 
magnetic stimulation (rTMS) or transcranial direct current stimulation 
(tDCS), are related to long-term changes in synaptic transmission 
analogue to long-term potentiation (LTP) and long-term depression 
(LTD) [21]. Several recent studies demonstrated that induction of LTP-
like effects (by facilitatory rTMS and tDCS) in the stroke hemisphere and 
LTD-like effects (by inhibitory rTMS and tDCS) in healthy hemisphere 
can enhance the effects of motor rehabilitation after stroke [22]. 
Nonetheless, the effects were limited and variable [23]. On the other 
hand, it was recently demonstrated that rTMS could improve learning via 
a different mechanism that involves the phenomenon of the so-called 
“homeostatic” plasticity. Indeed, it was classically demonstrated that 
neuronal and synaptic activity has a constant tendency toward a stable 
physiological condition (homeostasis) along with the different SNC 
systems. So when a system is perturbed, in the context of either a 
physiological phenomenon (i.e. learning or development) or a 
pathological condition (i.e. brain lesions), the system globally tends to 
reach a new equilibrium: this natural tendency towards a new stable 
condition is called homeostatic plasticity. In this context, it was elegantly 
demonstrated that a protocol capable of inducing LTD-like effects 
strongly facilitates motor learning (that is built up by LTP-like 
phenomena) while protocols inducing LTP-like effects have a less 
pronounced and short-lived facilitatory effect on learning [24].  
In the context of stroke this would predict that, contrary to usual 
practice that uses facilitatory protocols on the affected hemisphere, an 
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inhibitory rTMS protocol (that induces LTD-like effects) over the stroke 
hemisphere would lead to better relearning in stroke patients through 
mechanisms of homeostatic metaplasticity. 
The impact of stroke-induced motor deficit and its prevalence 
worldwide together with the great feasibility, relatively cheapness and 
the great safety of NIBS suggests a need to re-evaluate NIBS as an add-
on treatment to physical rehabilitation for post-stroke motor deficit [20]. 
Research efforts are needed for better studying the 
neurophysiological mechanism of recovery, and the significance of 
plastic changes observed after a brain lesion. Moreover, a “re-thinking” 
of the ways of application of NIBS after stroke is needed so far: 
systematic studies are warranted to better elucidate the effect of rTMS in 
relation to different parameters of stimulation and to evaluate new 
strategies of NIBS application. 
Increasing the knowledge in these fields will improve the 
therapeutical approach with this promising technique for promoting 
stroke recovery.  
 
Transcranial Magnetic Stimulation  
	
	
TMS was introduced by Barker and colleagues in 1985 as a non-
invasive technique for stimulating motor cortex in humans. A brief high-
current pulse through an insulated coil held over the scalp produces a 
single magnetic stimulus. Since the skull is characterized by little 
impedance to magnetic fields, magnetic pulse reaches cerebral cortex 
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inducing electric currents. When the current is induced in the motor 
cortex, at appropriate amplitude, duration, and direction, it depolarizes 
cortical neurons evoking a motor response in contralateral limb muscles, 
mainly hand muscles [25]. Since its introduction, TMS was largely used 
either in clinical or in research settings, not only to evaluate the 
functional integrity of the corticospinal tract but also for studying more 
complex phenomena such as excitatory and inhibitory effects depending 
on the activation of different neural elements in the stimulated area [26]. 
Paired pulse protocols are designed to give insight into the nature 
of the cortical circuitry activated by TMS [26]. 
Short interval intracortical inhibition (SICI) was the most used 
paired-pulse protocol and was described for the first time by Kujirai et al. 
(1993). When a subthreshold conditioning stimulus precedes a later 
suprathreshold test stimulus by using an interval between stimuli inferior 
to 5 ms, a clear inhibition of motor response is seen. Since the 
conditioning stimulus was below active motor threshold (AMT), the 
authors suggested that the interaction was occurring at a cortical level 
and that the conditioning stimulus was suppressing the recruitment of 
descending volleys by the test stimulus [27]. Furthermore, they 
suggested that SICI was GABA-ergic in origin and this hypothesis was 
posteriorly confirmed in further more recent studies from other groups 
[28,29]. Nevertheless, in vivo administration of agonists of GABA-A 
receptors increases the amount of SICI and also increases the inhibition 
of later descending I-waves [30]. 
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When two stimuli are given at an intensity at or above active 
motor threshold, facilitation can be observed between them if the 
intervals between the shocks is around 1.3, 2.5 and 4.3 ms. This 
interaction between the stimuli is thought to be due to interaction of I-
wave inputs in the periodic bombardment of pyramidal neurons [31]. 
Moreover, afferent inputs can modify the excitability of the motor 
cortex with a complex time course. Electrical stimulation, applied to 
peripheral nerves innervating the hand before a TMS pulse, could induce 
a very short latency inhibition of MEPs that was called short interval 
afferent inhibition (SAI) [32]. This inhibition begins about 1 ms after the 
latency of the N20 component of the sensory evoked potential and lasts 
for about 7 – 8 ms. Previous studies suggested that the inhibition was 
cortical in origin and this was confirmed in the recordings of descending 
volleys [33]. Administration of the muscarinic receptor blocker 
scopolamine reduced the amount of inhibition in both EMG and 
descending volley, suggesting that the pathway was under cholinergic 
control [34]. This data was indirectly confirmed in other studies dealing 
about patients affected by Alzheimer’s disease [35] in which a reduction 
of SAI was detected: the administration of rivastigmine, a cholinergic 






Repetitive Transcranial magnetic stimulation 
	
 
By delivering repetitive pulses of TMS (rTMS) it is possible to 
produce effects on cortical circuits that outlast the duration of the 
stimulation. Responses to single pulse TMS can be suppressed or 
facilitated depending on the frequency of the conditioning rTMS train: 
low frequency rTMS (1 Hz or less) delivered to the primary motor cortex 
produces a lasting decrease in corticospinal excitability [37]; conversely, 
high frequency rTMS (frequencies higher than 5 Hz), especially at high 
intensities of stimulation, leads to facilitatory after-effects on corticospinal 
circuits [38]. 
Moreover, different protocols of rTMS were developed: Huang 
and colleagues described a very rapid method of conditioning the human 
motor cortex using trains of magnetic stimuli similar to those used in 
animal experiments to induce long-term depression and long term 
potentiation, named theta burst stimulation (TBS) [39]. They described 
different patterns of stimulation with different effects on corticospinal 
excitability: the continuous theta burst stimulation paradigm (cTBS), (a 
40 second train of 3 pulses of 50Hz stimulation repeated every 200 ms 
for a total of 600 stimuli) produced a marked and long lasting 
suppression of motor cortex excitability and a significant reduction of 
glutamatergic-related intracortical facilitation; a second pattern of rTMS, 
the so-called intermittent theta burst stimulation (iTBS) (10 bursts of high 
frequency stimulation, 3 pulses at 50 Hz, are applied at 5 Hz every 10s 
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for a total of 600 pulses) produced a long lasting increase in motor 
cortex excitability [39]. 
The mechanisms of the modulation of cortical excitability are 
unclear, but they might be related to long-term changes in synaptic 
transmission similar to LTP and LTD equiparable to those seen in the 
hippocampus after its repeated stimulation [40]. rTMS is able to change 
and modulate activity beyond the stimulation period, so that it has 
therapeutic potential in patients with neurological and psychiatric 
disorders [41]. 
 
Safety of rTMS  
	
TMS was introduced more than 20 years ago in clinical 
neurophysiology and no severe adverse events have been reported. 
Rodent brains have shown no detectable injury after TMS [42]. Tissue 
from two adult patients with medically intractable epilepsy who 
underwent temporal lobe resections 4 weeks after approximately 2000 
stimuli, in an rTMS study, showed no changes attributable to rTMS [43]. 
The most serious documented side effect of rTMS is the induction of 
epileptic seizures caused by train of high stimulus intensities and 
frequency [44-46].  
rTMS can also induce bursts of electromyographic activity in 
several muscles contralateral to the stimulated hemisphere showing that 
trains of rTMS applied to the motor cortex induced a spread of cortical 
excitability. The spread of excitability depends on the intensity and 
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frequency of the stimuli and probably constitutes an early epileptogenic 
effect of rTMS [47].  
Guidelines for the safe combination of rTMS frequency, intensity 
and train length to stimulate the motor cortex of healthy subjects were 
established. It is unclear whether the established parameters are all safe 
if used to stimulate the motor cortex of chronic stroke patients who have 
an “epileptic” risk higher than healthy subjects [48]. Recently it has been 
reported that rTMS above threshold at 20 and 25 Hz is not safe for 
patients with chronic stroke [49]. However it should be considered that, 
till now, no serious side effect or seizure induction has been reported in 
studies exploring the effect of rTMS in stroke patients and in clinical trials 
applying rTMS in stroke recovery either when stimulation was delivered 




















Transcranial direct current stimulation (tDCS)  
	
 
tDCS involves the application of a low-intensity direct current (DC) 
(with an intensity of 1–2 mA), through two electrodes situated inside 
saline-soaked sponges and commonly applied over the scalp. These 
currents can induce depolarization or hyperpolarization of cortical 
neurons at a subthreshold level, dependent on polarity used: anodal 
stimulation depolarizes, while cathodal DCS hyperpolarize the 
underlying tissue [50]. This subthreshold modulation is achieved through 
particular electrodes montage on EEG mapped sites, permitting a 
somewhat focal stimulation of brain cortical areas. Although the precise 
mechanisms underlying its effects are not still known, there is a robust 
evidence demonstrating that tDCS is able to induce cortical excitability 
changes: these changes are present up to 1 h after the end of 
stimulation, when sufficiently long duration was used [51]. tDCS-induced 
cortical excitability changes were probed by means TMS in different 
studies and it was demonstrated that, depending on the polarity and 
intensity used, tDCS could modulate not only corticospinal (cortical 
motor output; i.e. MEP amplitude) but also intracortical excitability, such 
as intracortical inhibition and facilitation (i.e. gabaergic and glutamatergic 
intracortical networks) [52]. 
Furthermore, when compared to rTMS, tDCS is a relatively 
cheap, portable and relatively operator-independent technique: these 
characteristics permit a broader use of tDCS devices also out of 
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laboratory settings. Furthermore, the portability of tDCS devices renders 
the technique available for an “on-line” application, during some motor 
and rehabilitation tasks. Contemporary neuromodulation, in this case by 
means of tDCS, could boost the after-effects of physical therapy [4]. 
Furthermore, scientific evidence demonstrates that tDCS could be safely 
applied in stroke patients and that could change motor cortex excitability 





Main neurophysiological TMS hallmarks in stroke patients 
	
 
Stroke lesions interfere with the physiological coupling and 
balancing between the two sides of the brain, releasing unaffected 
hemisphere and suppressing the excitability of the affected one [20]. In 
other words, the main electrophysiological abnormality in stroke patients 
is represented by a contemporary reduced excitability of the affected 
motor cortex, indexed by an increased RMT and a decreased MEP 
amplitude, and a trend towards an increase in motor cortex excitability of 
the healthy hemisphere [54-57]. Furthermore, it was demonstrated that, 
even in a chronic phase (more than 1 year after the acute event) by 
performing a single session of either iTBS applied on the affected motor 
cortex or cTBS on the unaffected hemisphere, it is possible to induce an 
increase in motor cortex excitability of the affected hemisphere [58]. 
These data seem to confirm that the function of the affected hemisphere 
is disturbed both by the lesion, considering the increase of excitability 
after iTBS, and by the strong inhibitory influence of the unaffected 
hemisphere. Indeed, it was previously demonstrated that a lateralized 
focal brain lesion impairs the equilibrium of transcallosal reciprocal 
inhibition between the two hemisphere, leading to a reduction of 
trascallosal inhibition from AH towards UH and determining an 
exacerbate hypoexcitability of motor cortex of lesioned hemisphere with 
a negative influence on motor recovery [22,23]. Several 
neurophysiological and neuroimaging experimental findings are in favor 
of this theory: motor recovery seems to be related to reorganization 
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within the affected hemisphere, particularly linked to an enhancement of 
cortical excitability and a reduction of intracortical inhibition within AH. 
Thus, it could be suggested a possible mechanistic involvement of 
glutamatergic and GABAergic neurotransmission [59,60]. On the other 
hand it was demonstrated that TMS measure could provide a sort of 
prognostic factor for motor recovery: the absence of MEP after TMS of 
lesioned hemisphere, the absence of iTBS-induced MEP modulation on 
the affected hemisphere linealrly correlated with a bad prognosis, while a 
trend toward a not significant correlation was found between an increase 
of UH excitability and motor recovery [54, 58, 61]. 
These considerations and data fall again into the concept of post-
stroke inter-hemispheric competition model: the more motor cortical 
excitability difference between affected and unaffected hemisphere, the 
more the transcallosal inhibition from unaffected to affected hemisphere, 
the more the motor impairment in the affected hand [20]. 
Based on this theory, two strategies were mainly used to boost 
motor recovery after a stroke: increasing the excitability of affected 
hemisphere and reducing the excitability of the healthy one. 
 
 
rTMS delivered on affected hemisphere in stroke recovery 
	
 
It has been reported that rTMS with frequency of stimulation of 5 
Hz or more increase the excitability of motor cortex in normal subjects. 
Also in stroke patients is possible to externally modulate cortical 
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excitability. A direct evidence of an increase in corticospinal activity 
induced by rTMS of affected hemisphere in a stroke patient was 
provided in a patient with a dorsal epidural electrode [62]. This effect 
seems to be mediated by a selective reduction of the excitability of 
GABAergic networks in the human motor cortex [60] and decrease the 
GABA related inhibition facilitating practice-dependent plasticity [63]. 
These data suggest that rTMS of lesioned hemisphere could facilitate 
plasticity also by modulating GABA activity in the motor cortex. The first 
published report about the effect of rTMS for stroke recovery was by Uy 
et al [64]. They applied very low-frequency rTMS over lower limb motor 
area of affected hemisphere coupled with electric shocks in stroke 
patients in an observational not controlled: this protocol is named paired 
associative stimulation (PAS) that is demonstrated to increase motor 
cortex excitability when the used interstimulus interval (between 
electrical and magnetic stimuli) is more than 20 ms. Peripheral and 
cortical stimulation were applied 30 minutes every weekday for four 
weeks. Improvement in some neurophysiological and functional measure 
of affected lower limb was observed. Khedr et al. [65] studied a 
population of 52 unselected acute stroke patients receiving standard 
inpatient rehabilitation to improve the overall short-term outcome. They 
performed a sham-controlled study in which affected hemisphere hand 
motor area was stimulated at 3 Hz for 10 consecutive days. Real rTMS 
improved patients’ clinical scores (NIH Stroke Scale and Scandinavian 
Stroke Scale) more than sham stimulation (net change around 35%). 
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However, no benefit was observed in patients with massive 
middle cerebral artery infarct. 
 Kim et al [45] applied 10 Hz rTMS (a facilitatory rTMS protocol) in 
15 hemiparetic chronic stroke patients and observed its effects on 
corticospinal excitability and on motor learning. High-frequency rTMS 
resulted in a significantly larger increase in the MEP amplitude than the 
sham rTMS, and the change was positively associated with enhanced 
motor performance accuracy [66].  
In a proof of principle study Talelli and coworkers studied six 
chronic stroke patients with incomplete recovery of the hand under three 
conditions: excitatory TBS (iTBS) over the stroke hemisphere, inhibitory 
TBS (cTBS) over the intact hemisphere and sham stimulation. Only iTBS 
over AH was able to shorten reaction time in paretic hand and increase 
the excitability of the lesioned. Inhibitory TBS over the healthy 
hemisphere suppressed the MEPs evoked in the healthy hands but did 
not change motor behaviour or the electrophysiology of the paretic 
hands [67]. Subsequently, in a double-blind placebo control study, 
developed in collaboration with our group, it was demonstrated that in a 
population of chronic stroke patients with mild to moderate deficits of 
upper-limb function, TBS did not augment the gains from a retraining 
protocol for the upper limb. This study suggests that the concept of a 
boosting-rehabilitation effect by rTMS for stroke patients is perhaps 
simplistic. In sum, it was suggested that expectations regarding effect 
sizes should be reconsidered and, instead of adding treatments together 
hoping to achieve better results, attention should be focused on 
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identifying the patients most likely to respond to a particular intervention 
[68].  
 
rTMS delivered on healthy hemisphere in stroke recovery 
	
 
Studies in normal subjects showed that low-frequency rTMS is 
able to increase the excitability of the contralateral motor cortex and 
reduce the inter-hemispheric inhibition from the stimulated-to-
contralateral hemisphere [69] and that could shorten the execution time 
of a motor task with the ipsilateral hand without affecting performance of 
the contralateral hand [70]. 
The first relevant study aimed at evaluating changes in motor 
function of affected hand induced by rTMS in stroke patients, employed 
1 Hz rTMS protocol applied to UH. The authors did not find any 
significant effect on motor function of the paretic hand [71]. Conversely 
another research group found that 1 Hz rTMS applied over UH for 10 
minutes and with lower intensities in 10 stroke patients induced a 
significant reduction in simple and choice reaction time and improved 
performance in affected hand [72]. These results were confirmed in 
further studies, in which a modulation of duration trans-callosal inhibition 
was also demonstrated [73] and in which safety and long-lasting effects 
after 5 consecutive daily sessions of stimulation were shown [74,75].  
In general, although safety and feasibility of application of rTMS in 
both AH and UH is largely confirmed, studies combining standard 
rehabilitation with rTMS protocols that enhance ipsilesional excitability or 
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suppress contralesional excitability, based on a non-homeostatic 
interaction of brain stimulation and motor training, have generated 
conflicting and variable results [76]. 
 
TDCS in motor recovery after stroke 
	
	
In recent years, the number of studies about the efficacy of tDCS 
as an add-on treatment has drastically increased. However, although 
results are generally promising, there is a great variability in the size-
effect and in the methodologies used, as such as stimulation montage, 
intensity, duration and type of outcome measures.  
tDCS application to enhance motor recovery after a stroke was 
mostly based, as like as the application of rTMS, on the concept of a 
maladaptive interhemispheric disequilibrium [77]. As already stated, the 
existence of this contralesional inhibitory influence is associated with 
greater severity of impairment and poorer rehabilitative outcomes [67]. 
tDCS is thought to be able to directly reverse this imbalance: differently 
from rTMS, although tDCS could be applied monolaterally upregulating 
AH (anodal stimulation), or downregulating UH (cathodal stimulation), 
the advantage of tDCS is represented by the use of both approaches 
simultaneously (bihemispheric stimulation).  
It was hypothesized that anodal tDCS could modulate sodium 
(Na+ ) and calcium (Ca2+ ) ion channels, NMDA receptors and Gamma-
Aminobutyric acid (GABA)-ergic interneurons [51,52]: anodal stimulation 
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effects are erased when subjects were given Na+ and Ca2+ ion channel 
blockers and NMDA receptor antagonist block long-term effects [78]. 
Magnetic resonance spectroscopy also revealed that anodal 
stimulation could effectively inhibit tonic GABA-ergic activity [79]. 
Contemporary it was also demonstrated that SICI could be suppressed 
after a stroke in AH and that motor function recovery has a negative 
correlation with SICI [80]. Taken together, anodal tDCS, by reducing the 
GABA-ergic tone in the lesioned cortex, may represent a good strategy 
to reach an improvement in motor recovery. 
UH can be downregulated by means of cathodal stimulation. As 
like as anodal stimulation, cathodal tDCS depend on NMDA receptors 
function as well as glutamatergic synapses and interneurons [51,52]. 
Unlike anodal stimulation though, the administration of Na+ and Ca2+ 
ion channel blockers had no effect on cathodal after-effects [78]. When 
anodal and cathodal stimulation are performed contemporary, placing 
anode on a motor cortex and cathode on the other one, motor 
performance in the hemisphere stimulated by anode much more than 
when the same hemisphere was stimulated using unilateral anodal tDCS 
[81].  
In a different study on a group of healthy subjects, it was 
demonstrated that when a bilateral montage was used (i.e. cathode on a 
motor cortex and anode on the contralateral one), the effects under the 
cathode were similar to those induced by monolateral tDCS, while the 
contralateral effects had a greater size when compared to unilateral 
cathodal stimulation [82].  
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The subtle differences in mechanism of action between anodal 
and cathodal tDCS, together with their gross opposite effects on motor 
cortex excitability and the possibility of applying them contemporary on 
lesioned and healthy motor cortex represent a clear advantage in its 
application for a better motor function recovery after a stroke. 
Rationale for the compendium 
Rationale for the compendium  
	
 
Non-invasive brain stimulation technique approach needs to be 
validated yet, keeping particular attention to the expected effect size and 
the selection of patients that could beneficiate from that. 
In stroke patients cohorts, the stimulation of affected hemisphere, 
that, although the high variability of the available data seems one of the 
most effective strategy, was criticized mainly for safety concern [83] 
even tough no relevant adverse event have been reported in the pilot 
studies in which affected hemisphere was stimulated even in acute 
phase [48].  
For these reasons, at the moment, rTMS for promoting stroke 
recovery should be used only in research laboratories with experience in 
rTMS and strictly respecting safety guidelines, even for stimulation of 
healthy hemisphere [48].  
Furthermore the spectrum of stroke patients is characterized by 
large inter-subjects variability, depending on different parameters as 
such as age, sex risk factors and, more importantly, lesions’ site (cortical 
vs subcortical) and lesions’ volume (small lesions vs large lesions), the 
lasts accounting for great differences in the recovery prediction. On the 
other hand, the conflicting results from the NIBS application in promoting 
motor recovery after a stroke could also depend on the particular 
neuromodulation protocol applied: within the “family” of inhibitory and 
facilitatory protocols, each one account for subtle differences in the 
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mechanisms of action that could affect the ultimate results. Moreover, it 
was recently demonstrated that genetic background of the patients (see 
BDNF polymorphisms) could influence the after-effects of 
neuromodulatory protocols as well as could account (at least in part) for 
the individual variability in the spontaneous recovery after a stroke in 
selected cohorts of patients.   
Nevertheless, it seems evident that “correction” of inter-
hemispheric imbalance, which was the rationale of the majority of the 
previous studies, failed to obtain univocal and positive results. On the 
other hand, till now it is not well-known the role of stroke-related UH 
disinhibition: a recent study showed that application of TMS pulses over 
the UH hand motor area of well-recovered chronic stroke patients 
caused a worsening in complex finger movements, suggesting a 
compensatory and not detrimental role of the increased UH excitability 
[84].  
In line with these findings, few studies demonstrated that the 
suppression of UH excitability (following the theory of the detrimental 
inter-hemispheric imbalance) worsens the residual motor abilities in the 
paretic hand [85]. Furthermore it is well known that a small “ipsilateral” 
descending motor pathways exists and it is thought to participate mainly 
in unimanual motor tasks [86]. Consequently, suppressing UH or 
boosting the excitability of AH could be not the “right” strategy and the 
opposite approach could be considered, in which the hyperexcitability of 
UH positively participate in motor recovery: this model is called 
vicariation/compensatory model.  
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Moreover, one recent experimental study in a rat model of stroke 
showed that the artificial reduction of the excitability of UH led to a 
reduction in motor performance of the paretic forelimb and that the 
smaller the lesion, the smaller the worsening [87]. With these 
considerations in mind, Di Pino and colleagues proposed a new model 
for a tailored treatment in stroke patients, in which competition model 
should be preferred with small lesions and vicariation/compensatory 
model with big lesions [88]. 
	
Hypothesis and objectives 
 
Hypothesis and objectives 
 
In the last 6 years my efforts concentrated in the study of the 
pathophysiology of stroke and motor recovery after a brain lesion. 
Particularly we built a line of research in which we concentrated in 
improving NIBS application to boost motor recovery.  
In line with these hallmarks, it jumps to attention that NBS is not a 
“one size fits all” solution for recovery after stroke [89]: this could be true 
for different aspects, such as inter-individual variability in stroke cohorts, 
brain lesions variability and the subtle differences between different 
neuromodulation techniques.  
In this compendium I tried to address the following open 
questions about the application of NIBS in post-stroke motor deficit: 
1) The subtle differences between the different NIBS techniques.  
2) The significance of plastic changes observed after a brain 
lesion.  
3) The existence (or not) of neurophysiological predictors of NIBS 
effects in stroke patients.  
4) The existence of other NIBS strategy based on new insights of 
the contribution of the plastic changes induced by the brain lesion. 
 
In order to look for subtle differences between neuromodulation 
protocols that commonly lead to similar final changes in motor cortex 
excitability (i.e. increase), we had the great opportunity to study a solid 
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genetic human model as like as Costello Syndrome (CS), in which a 
single “gain-of-function” mutation enhances the functionality of the Ras 
signaling and leads to a detrimental increase in LTP-phenomena. So 
that, by applying in CS patients two similar neuromodulation protocols 
capable of inducing LTP, we aimed to disclose any subtle and hidden 
differences between two similar neuromodulation techniques, by 
evaluating the influence of a particular mutation in the HRAS system on 
the effects of TBS and PAS rTMS protocols (paper 1).  
Afterwards, in a group of acute stroke patients we explored 
intracortical excitability of both hemisphere and looked for a possible 
correlation with motor recovery (paper 2). 
Subsequently, in a different study, we tested whether the 
contemporary application of an excitatory neuromodulation over the 
affected hemisphere and an inhibitory neuromodulation over the 
unaffected hemisphere (following the idea of the inter-hemispheric 
competition/rivalry theory) in the sub-acute phase of a stroke could 
enhance motor recovery (paper 3).  
At last we also tested, in a different group of patients, if, by the 
application of an inhibitory neuromodulation over the affected 
hemisphere in chronic stroke patients (by using the rationale of the 
vicariation/compensation model, in which the increased excitability of the 
UH is considered compensatory and not detrimental) could improve 





Paper 1: Differential Effects of HRAS Mutation on LTP-Like 
Activity Induced by Different Protocols of Repetitive 
Transcranial Magnetic Stimulation 
 
 
We included four patients (mean age: 20.57 ± 4.57 years; age 
range: 17–27 years) with molecularly confirmed diagnosis of Costello 
Syndrome. Diagnosis was obtained in relation to clinical characteristics 
and was confirmed by mutational screening of the HRAS gene [90]. 
None of the patients was taking drugs acting on CNS or was affected by 
epilepsy.  
A total of 21 age-matched healthy subjects (mean age: 22.1 ± 
4.14 years; CS patients vs controls unpaired t-test: p = 0.43; age range: 
16–34 years) participated in the experiments as a control group.  
The present study comprised two independent experiments. Both 
the experiments consist in three sessions per participant.  
Focal TMS of the right hand M1 was performed with a high power 
Magstim 200 (Magstim Co., Whitland, Dyfed) by using a figure-of-eight 
coil with external loop diameters of 7 cm held over the right motor cortex 
at the optimum scalp position to elicit motor responses in the 
contralateral FDI. Recordings were made from the relaxed first dorsal 
interosseous muscle (FDI) of the left hand for both groups. The 
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responses to 20 stimuli obtained at rest at an intensity of 120% RMT 
were averaged.  
iTBS: the protocol was delivered to the right motor cortex over the 
“hot spot” for the contralateral FDI muscle using a MagPro stimulator 
(Medtronic A/S Denmark) connected to a figure-of-eight coil (MCF B65). 
The initial direction of the current induced in the brain was anterior to 
posterior. The magnetic stimulus had a biphasic waveform. The 
stimulation intensity was defined in re- lation to AMT evaluated using the 
MagPro stimulator. An intensity of 80% AMT was used. ITBS protocol 
consists in the following paradigm: 20 bursts of high frequency 
stimulation (3 pulses at 50 Hz) are applied at 5 Hz every 10 s for a total 
of 600 pulses. 
 
Paired associative stimulation (PAS): The intervention 
consisted of single electrical stimuli delivered to the left ulnar nerve at 
the wrist at 300% of the sensory perceptual threshold (SPT), followed by 
TMS at an intensity sufficient to produce an unconditioned response 
amplitude of approximately 1 mV in the resting FDI. Ninety pairs were 
delivered at 0.05 Hz over 30 min at an interstimulus interval (ISI) of 25 
ms. An ISI of 25 ms was used because this interval had been shown in 
previous experiments to be effective in increasing cortical excitability 
[91]. 
 
Experimental design: We evaluated motor thresholds and MEP 
amplitudes in all CS patients and all the healthy subjects in baseline 
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conditions. In all CS patients and in 16 control subjects we probed the 
effects of a single session application of iTBS on motor thresholds and 
MEP amplitudes at two time points, 7 minutes and 30 minutes after the 
end of iTBS. In all CS patients and in 14 healthy subjects we evaluated 
the effects of a single session of PAS on motor thresholds and MEP 
amplitudes at two time points, immediately after and 30 minutes after the 
end of PAS to replicate the results of our previous study [87]. After TBS 
and PAS, the amplitude of MEPs was measured using the same 
stimulus intensity used in baseline conditions even when there was a 
change in RMT. Twenty sweeps of the data were collected, and the 




Paper 2: The Level of Cortical Afferent Inhibition in Acute 




Sixteen patients (mean age, 66.8+13.4 years) with first-ever 
stroke were recruited. Acute-phase evaluation was based on the 
National Institutes of Health Stroke Scale. Outcome at 6 months was 
assessed using modified Rankin Scale (mRS). This study was 
performed according to the Declaration of Helsinki and was approved by 




Patients underwent brain magnetic resonance imaging. Seven 
patients had a subcortical stroke, whereas 9 patients showed cortical 
and subcortical involvement. To evaluate whether SAI changes were 
correlated with structural abnormalities of cholinergic systems, we 
estimated the damage extent of pathways emanating from nucleus 
basalis of Meynert: medial pathway, Capsular Lateral pathway, and 
Perisylvian Lateral pathway [92].  
We evaluated active motor threshold and resting motor threshold, 
amplitude of motor-evoked potentials (MEP), SICI at 2 ms inter-stimulus 
interval, and SAI at interstimulus intervals from N20 latency plus 2, 3, 
and 4 ms. We evaluated both affected hemispheres (AH) and unaffected 
hemispheres (UH). 
Because it has been suggested that a change in the slope of 
input– output curve may influence the amount of cortical inhibition, we 
also obtained AH input–output curve using increasing stimulus 
intensities and evaluated whether there was a correlation between slope 
of input–output curves and amount of AH-SAI [93]. 
Data obtained in patients were compared with those obtained in 










Paper 3: Immediate and late modulation of interhemipheric 
imbalance with bilateral transcranial direct current stimulation 
in acute stroke 
 
 
14 patients were recruited for the first experiment: 7 patients 
underwent real bilateral tDCS and 7 patients underwent sham tDCS. 
Twenty patients were recruited for the second experiment, 10 patients 
underwent real bilateral tDCS and 10 patients underwent sham tDCS. 
Real/sham tDCS was applied for five continuous days, for 40-min 
per day. The investigators who applied real/sham tDCS were kept blind 
to the intervention by using the pre-programmed stimulation mode in the 
stimulator settings. Participants received tDCS over the primary motor 
cortex (M1) bilaterally. The excitability-enhancing anode electrode was 
placed over the primary motor cortex of the AH (C3 or C4 in the 10/20 
international EEG system, depending on the lesion side). The 
excitability-diminishing cathode electrode was placed over the 
contralateral primary motor cortex of the UH (C3/C4 depending on the 
lesion side). This montage allows a simultaneous inhibition of the M1 
activity in the UH and stimulation in the affected M1. The stimulation 
parameters were: intensity of 2 mA for 40 min with a current density of 
0.057 mA/cm2 (10 s of fade-in and fade-out). We used the same 
montage as tested by Bolognini et al. and ensured a minimal distance 






Experiment 1: short term clinical effects of tDCS 
All patients underwent a standardized protocol of rehabilitation 
based on physical therapy. An evaluator, blinded to the treatment, 
assessed the effects of the interventions before the beginning of 
treatment (baseline assessmentet0) and 1 week after (2 days after the 
end of the treatmentet1) using the following validated measures 
sensitive to hand function changes: (i) Action Research Arm Test 
(ARAT); (ii) 9 Hole Peg Test (9HPT); (iii) Hand- grip strength; (iv) Motor 
Activity Log Rating Scale (MAL); (v) Score on the National Institutes of 
Health stroke scale (NIHSS); (vi) modified Rankin Scale score to assess 
stroke-related disability; (vii) Adverse event monitoring and reporting. 
 
Experiment 2: short- and long-term clinical and electrophysiological 
effects of tDCS associated with constraint-induced movement therapy 
Subjects enrolled in experiment 2 were treated with the asso- 
ciation of physical rehabilitation with real/sham bilateral tDCS. All the 
subjects underwent constraint-induced movement therapy (CIMT), while 
they were randomized in two groups that received either real or sham 
bilateral tDCS. 
Along 5 days of physical rehabilitation, real/sham tDCS was 
applied for 40-min during the motor training session, starting 5 min 
before the beginning of the session.  
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CIMT was administered for five days by a trained therapist, who 
was not involved in the pre-post evaluations. The therapy consisted of 
the association of training tasks designed according to behavioral 
“shaping” technique while wearing, on the non-paretic hand, a resting 
splint secured in a sling, which hindered hand and finger activity (SkiL-
Care Rigid Palm Padded Mitt; AliMed, Inc, Dedham, Massachusetts). 
The splint had to be worn for at least 90% of waking hours [94]. During 
the 5 days of the treatment period, all patients received 1.5 h per day of 
training of the affected arm in the laboratory [95]. Training tasks were 
designed to force an intensive use of the paretic extremity, while 
requiring a progressive improvement of the quality of movement [96]. 
Nine different shaping tasks were used during this 1.5-h period, which 
included buttoning a shirt, pouring water, and folding towel. 
As part of experiment 2, patients were evaluated at baseline (t0), 
one week after (t1) and at 3-month follow-up. In these patients, we also 
explored motor cortex excitability of the AH and UH and the effects of 
the treatment (Bilateral tDCS and CIMT) on the propensity of the motor 






Paper 4: Inhibitory theta burst stimulation of affected 




12 chronic stroke patients gave their written informed consent for 
the study, which was performed according to the Declaration of Helsinki 
and approved by the local ethics committee. The National Institute of 
Health Stroke Scale (NIHSS) and the Barthel Index (BI) were used to 
evaluate neurological impair- ment and disability at the enrolment. Since 
this was an exploratory trial in which we aimed to evaluate changes in 
global hand function, we chose 3 primary outcome measures that 
evaluate different aspects of that. These were Action Research Arm Test 
(ARAT; score 0–57), Jebsen-Taylor Test (JTT) and Nine Hole Pegboard 
Test (NHPT). 
We evaluated changes in motor cortex excitability in a subgroup 
of patients [4 in the real group (mean age: 59.5 ± 11.7 (SD) years) and 4 
in the sham group (age: 56.7 ± 16.1; p = 0.5)] of both affected (AH) and 
unaffected (UH) hemisphere at baseline, T1 and T2. 
Continuous Theta Burst Stimulation (cTBS), in which 3 pulses are 
given at 50 Hz, repeated every 200 ms for a total of 600 pulses at a 
stimulation intensity of 80% AMT, was applied over hand motor cortex of 
the affected hemisphere. 6 patients underwent real cTBS and 6 patients 




Physical therapy included strength training for the wrist, fingers 
and thumb and grasp and repetitive task practice; the latter aimed mainly 
at hand function, including, however, proximal elements through 
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A B S T R A C T
Background: Costello syndrome (CS) is a rare congenital disorder due to a G12S amino acid substitution
in HRAS protoncogene. Previous studies have shown that Paired Associative Stimulation (PAS), a repet-
itive brain stimulation protocol inducing motor cortex plasticity by coupling peripheral nerve stimulation
with brain stimulation, leads to an extremely pronounced motor cortex excitability increase in CS pa-
tients. Intermittent Theta Burst Stimulation (iTBS) represents a protocol able to induce motor cortex plasticity
by trains of stimuli at 50 Hz. In healthy subjects PAS and iTBS produce similar after-effects in motor cortex
excitability. Experimental models showed that HRAS-dependent signalling pathways differently affect
LTP induced by different patterns of repetitive synaptic stimulation.
Objective: We aimed to compare iTBS-induced after-effects on motor cortex excitability with those pro-
duced by PAS in CS patients and to observe whether HRAS mutation differentially affects two different
forms of neuromodulation protocols.
Methods: We evaluated in vivo after-effects induced by PAS and iTBS applied over the right motor cortex
in 4 CS patients and in 21 healthy age-matched controls.
Results: Our findings confirmed HRAS-dependent extremely pronounced PAS-induced after-effects and
showed for the first time that iTBS induces no change in MEP amplitude in CS patients whereas both
protocols lead to an increase of about 50% in controls.
Conclusions: CS patients are characterized by an impairment of iTBS-related LTP-like phenomena besides
enhanced PAS-induced after-effects, suggesting that HRAS-dependent signalling pathways have a dif-
ferential influence on PAS- and iTBS-induced plasticity in humans.
© 2015 Elsevier Inc. All rights reserved.
Introduction
Costello syndrome (CS; [MIM] 218040) is a rare congenital dis-
order due to a G12S amino acid substitution in HRAS protoncogene
[1] which presents relatively homogeneous clinical phenotype com-
prising craniofacial anomalies, characteristic cardiac and skeletal
problems, developmental delay, mental retardation and certain pre-
disposition to malignancies development [2–4]. Ras genes encode
small guanosine triphosphatases (GTPases) that are abundantly ex-
pressed in the adult CNS [5]. Several lines of evidence indicate that
RAS signalling plays a key role in the mechanisms underlying long-
term potentiation (LTP) and learning [6–8].
LTP phenomena have been mostly studied in laboratory set-
tings by using mice brain slice preparation, but the recent
introduction of repetitive transcranial magnetic stimulation (rTMS),
a non invasive technique able to lastingly modulate the excitabil-
ity of cortico-spinal and cortico-cortical pathways, has provided a
chance for “in vivo” evaluation of LTP-like phenomena [9–12].
* Corresponding author. Tel.: +34925247723; fax: +34925247745.
E-mail addresses: dileone.michele@ulssvicenza.it; dileone.michele@gmail.com
(M. Dileone).
1935-861X/© 2015 Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.brs.2015.08.012
Brain Stimulation 9 (2016) 33–38
Contents lists available at ScienceDirect
Brain Stimulation





Intermittent theta-burst stimulation (iTBS) is a rTMS protocol,
able to induce a lasting increase in motor cortex excitability by using
trains of low intensity stimuli and its after-effects, originating at cor-
tical level [13], are dependent on the N-methyl-d-aspartic acid
(NMDA) receptors and are linked to motor learning and functional
recovery after stroke, suggesting a similarity with those of synap-
tic LTP [14,15]. It was recently shown that iTBS increases the
excitability of cortico-cortical connections of the motor cortex that
generate late I-waves in normal subjects as like as another rTMS
paradigm called Paired Associative Stimulation (PAS) [16,17]. PAS,
obtained by coupling peripheral nerve stimulation with motor cortex
stimulation, is based on the Hebbian concept of spike-timing-
dependent plasticity [11]. In healthy subjects iTBS and PAS induce
similar after-effects on motor cortex excitability [12].
We recently observed a pronounced enhancement of PAS-
induced after-effects [18] and the presence of dystonic features in
CS [19] in line with previous findings according to which PAS ab-
normality is involved in the pathophysiology of dystonia [20].
Furthermore, recently it has been demonstrated that PAS enhance-
ment is paralleled by a reduction of iTBS-induced effects in focal
hand dystonia (FHD) [21].
Experimental studies have shown that HRAS-dependent signal-
ling pathways in LTP depend on the pattern of synaptic stimulation
used [22]. Thus, CS represents a unique model for evaluating “in vivo”
the relation between HRAS-linked intracellular signalling and LTP-
like activity produced by different protocols of non-invasive brain
stimulation. The aim of present study was to evaluate PAS- and iTBS-
induced brain plasticity in CS patients.
Methods
Ethical approval
The study was performed according to the Declaration of Hel-
sinki and approved by the local Ethics Committee. Informed consent
was obtained based on a protocol approved by the institutional review
board obtaining the consensus both from patients and their parents
after a detailed explanation of the procedures and the aims of the
study. The healthy subjects were also informed about the aim of the
study and gave their written consent. rTMS was performed accord-
ing to the recently published guidelines for the use of repetitive
transcranial magnetic stimulation in subjects under 18 years [23].
Patients
The study included four patients (mean age: 20.57 ± 4.57 years;
age range: 17–27 years) with molecularly confirmed diagnosis.
Diagnosis was obtained in relation to clinical characteristics and was
confirmed by mutational screening of the HRAS gene. None of the
patients was taking drugs acting on CNS or was affected by epilepsy.
Three patients (patients 1, 2 and 3) were included in a previous paper
investigating selectively PAS after effects and were re-evaluated
2 years later.
As in the previous paper by our group [18] Costello patients were
evaluated by using the Unified Dystonia Rating Scale (UDRS) Revised
score and the Global Dystonia Scale (GDS) in order to quantify dys-
tonic symptoms (Table 1). As described in one previous study from
our group, dystonic symptoms in CS go from axial to generalized
dystonia, both fluctuating and more evident during walking. Some
degree of dystonia was present also at rest [23]. For all the pa-
tients, brain and cervical spinal cord magnetic resonance imaging
(MRI) were available.
A total of 21 age-matched subjects (mean age: 22.1 ± 4.14 years;
CS patients vs controls unpaired t-test: p = 0.43; age range:
16–34 years) with no known history of neurological disease
participated in one or both experiments of the present study to
compare their results with those obtained in CS patients. All the
studied subjects were right-handed. Nine subjects participated in
both experiments.
The present study comprised two independent experiments. Both
the experiments consist in three sessions per participant.
Transcranial magnetic stimulation
Focal TMS of the right hand M1 was performed with a high power
Magstim 200 (Magstim Co., Whitland, Dyfed). A figure-of-eight coil
with external loop diameters of 9 cm was held over the right motor
cortex at the optimum scalp position to elicit motor responses in
the contralateral FDI. We decided a priori to study right motor cortex
both in controls and in CS patients because dystonic symptoms were
symmetric. Intensities were expressed as a percentage of the
maximum output of the stimulator.
Resting motor threshold (RMT) was defined according to the rec-
ommendations of the IFCN Committee [21] as the minimum stimulus
intensity that produced a liminal MEP (>50 μV in 50% of 10 trials)
with the tested muscle at rest. The active motor threshold (AMT)
was defined as the minimum stimulus intensity that produced a
liminal MEP (about 200 μV in 50% of 10 trials) during isometric con-
traction of the tested muscle. Throughout the entire study, both for
patients and for healthy subjects, we used an orientation of the
stimulating coil over the motor strip with the handle pointing back-
wards, with the induced current flowing in a posterior–anterior (PA)
direction.
Table 1
Neurologic, MRI and neuropsychological features in the subjects with Costello syn-
drome, heterozygous for the c.34G > A missense change (Gly12Ser) in HRAS, included
in the study.
Patient 1 Patient 2 Patient 3 Patient 4
Sex M F F F
Age (y) 19 17 27 18
Global dystonia Scale 7 6 12 7
Unified Dystonia Rating Scale 5 4 9 6
PAS-induced MEP increase (%) 246* 213* 329* 207*
iTBS-induced MEP increase (%) 3.7** −20** 3.2** −3.6**
Epilepsy – – – –
MRI anomalies – Ch Ch –
Facial
“Coarse” face + + + +
Epicanthus + + + +
Strabismus + + + +
Depressed and wide nasal bridge + + + +
Bulbous tip of nose – + + +
Fleshy and cocked auricular lobes + + + +
Low set/posteriorly angulated ears + + + +
Full cheeks + + + +
Macrostomy/thick lips + + + +
Hoarse and deep voice + + + +
Osteoarticular
Short neck + + + +
Ulnar deviation of fingers + + + +
Interphalangeal laxity of fingers + + + +
Limited extension of joints E, H, A E E, H, A H, A
Spine K S HI, S S
A, achilles tendon; Ch: Chiari 1 malformation; E, elbow; H, hip; Hl, hyperlordosis;
K, kyphoscoliosis; S, scoliosis; n.e., not evaluated.
* We calculated the upper normal limit of PAS-induced MEP increase in 14 age-
matched controls as the mean
MEP increase (%) plus 2 SD, the mean percentage increase in controls was 78% ± 65%,
so that an increase greater than 208% was considered outside the normal limits.
** We calculated the lower normal limit of iTBS-induced MEP increase in 17 age-
matched controls as the mean
MEP increase (%) less 2 SD, the mean percentage increase in controls was 52% ± 17.8%,
so that an increase smaller than 16% was considered outside the normal limits.





MEPs were band pass filtered (bandwidth 3 Hz–3 kHz) (Digitimer
D360 amplifiers) and each single trial was recorded on computer
for later analysis using a CED 1401 A/D converter (Cambridge Elec-
tronic Design, Cambridge, UK) and associated software. Recordings
were made from the relaxed first dorsal interosseous muscle (FDI)
of the left hand for both groups. The responses to 20 stimuli ob-
tained at rest at an intensity of 120% RMT were averaged. Subjects
were given audio-visual feedback of the EMG signal at high gain to
assist in maintaining complete relaxation; trials contaminated by
EMG activity were discarded.
Intermittent theta burst stimulation
iTBS was delivered to the right motor cortex over the “hot spot”
for the contralateral FDI muscle using a MagPro stimulator
(Medtronic A/S Denmark) connected to a figure-of-eight coil (MCF
B65). The initial direction of the current induced in the brain was
anterior to posterior. The magnetic stimulus had a biphasic wave-
form with a pulse width of about 280 μs and maximum magnetic
field strength of 1.5 T. The stimulation intensity was defined in re-
lation to AMT evaluated using the MagPro stimulator. An intensity
of 80% AMT was used. ITBS protocol consists in the following par-
adigm: 20 bursts of high frequency stimulation (3 pulses at 50 Hz)
are applied at 5 Hz every 10 s for a total of 600 pulses.
Paired associative stimulation
We used a high power Magstim 200 (Magstim Co., Whitland,
Dyfed, UK) connected to a figure-of-eight coil, with external loop
diameters of 9 cm held over the right motor cortex at the optimum
scalp position to elicit MEPs in the contralateral FDI. The induced
monophasic current in the brain flowed in a posterior-to-anterior
direction. The intervention consisted of single electrical stimuli de-
livered to the left ulnar nerve at the wrist at 300% of the sensory
perceptual threshold (SPT), followed by TMS at an intensity suffi-
cient to produce an unconditioned response amplitude of
approximately 1 mV in the resting FDI. Ninety pairs were deliv-
ered at 0.05 Hz over 30 min at an interstimulus interval (ISI) of 25 ms.
An ISI of 25 ms was used because this interval had been shown in
previous experiments to be effective in increasing cortical excitability
[11].
Experimental design
We evaluated motor thresholds and MEP amplitudes in all CS
patients and all the healthy subjects in baseline conditions.
In all CS patients and in 16 control subjects (mean age:
23.2 ± 3.8 years; CS patients vs controls unpaired t-test: p = 0.2) we
probed the effects of a single session application of iTBS on motor
thresholds and MEP amplitudes at two time points, 7 minutes and
30 minutes after the end of iTBS.
In all CS patients and in 14 healthy subjects (mean age:
23.1 ± 5 years; CS patients vs controls unpaired t-test: p = 0.32) we
evaluated the effects of a single session of PAS on motor thresholds
and MEP amplitudes at two time points, immediately after and
30 minutes after the end of PAS to replicate the results of our
previous study [18].
After TBS and PAS, the amplitude of MEPs was measured using
the same stimulus intensity used in baseline conditions even when
there was a change in RMT. Twenty sweeps of the data were col-
lected, and the mean peak-to-peak amplitude of MEPs was calculated
for each studied groups.
Seven healthy subjects participated only in iTBS experiment, five
healthy subjects only in PAS experiment and nine subjects in both
the experiments.
For each CS patient and each subject that participated in both
the experiments the intersession interval was at least 1 week to
exclude interactions between sessions.
Since some degree of dystonia was present also at rest, we also
measured mean rectified EMG activity 100 ms before the stimulus
artifact and trials in which EMG activity exceeded ±2.0 SD of the
mean resting EMG were excluded from further analysis both for CS
patients and controls. A total of 5.6 ± 2.3% trials (both iTBS and PAS
sessions) were discarded in CS group and a total of 5.3 ± 1.8% in
controls.
Statistics
Since we focused on any difference between iTBS and PAS-
induced after-effects upon baseline motor cortex excitability in CS
patients, baseline MEP amplitude, RMT and AMT and their changes
after each rTMS protocol were compared in Costello patients. Nev-
ertheless we aimed to disclose any difference in the after-effects of
each rTMS protocol (iTBS and PAS) between CS patients and the
group of age-matched controls.
To compare motor thresholds between the two groups (Costello
patients vs healthy controls) and after each rTMS protocol we used
a four-way factorial ANOVA with TIME (t0, t1, t2), PARAMETER (RMT,
AMT) and STIMULATION (iTBS, PAS) as within-subject factors and
GROUP (CS patients and controls) as between-subjects factor. To
compare MEP amplitudes we used a separated three-way factorial
ANOVA with TIME (T0, T1, T2) and STIMULATION (iTBS, PAS) as
within-subject factor and GROUP (Costello and controls) as between-
subjects factor. When significant main effects or interactions were
found, post hoc t-tests with correction for multiple comparisons
were performed. The level of significance was set at P < 0.05.
Before entering ANOVA, since we studied only 4 CS patients and
this number is too small to assume normality, all the raw data were
tested for normality by using Shapiro–Wilk test and for sphericity
by using Mauchly’s sphericity test and, furthermore, we decided to
normalize the spread of MEP amplitudes dividing them by the grand
mean of the baseline mean values of each group. Using this method,
the baseline mean is always equal to 1 but with the same variance
as that of the raw data.
To obtain a measure of reproducibility of the PAS after-effects
in this rare condition, since 3 out of 4 CS patients included in the
present paper were enrolled in a previous paper by our group dealing
with PAS after-effects in Costello disease, we compared, by means
of 3 different unpaired t-tests, MEP amplitude at the 3 studied time
points for the patients that participated in both studies.
To assess a possible correlation between dystonia and the degree
of MEP changes in CS patients, we performed Pearson’s Chi-
squared correlation test for both PAS effects and iTBS effects (MEP
changes) vs GDS scores.
Results
None of the patients and controls experienced any adverse event
during and after the application of rTMS protocols. No significant
difference was found in baseline cortical excitability parameters
between patients and controls. ANOVA for motor thresholds showed
no significant TIME × STIMULATION × GROUP interactions (F1,32 = 0.11;
p = 0.74).
Details about the mean values of RMT, AMT, and MEP ampli-
tude in baseline condition are reported in Table 2.
ANOVA for baseline-normalized MEPs revealed a significant
TIME × STIMULATION × GROUP interaction (F1,16 = 19.372; P < 0.001).
Post-hoc unpaired t-test showed no statistical difference for base-
line MEPs between CS patients and controls and between the two
control groups [CS (iTBS) vs controls (iTBS) p = 0.99; CS (iTBS) vs





controls (PAS) p = 0.6; CS (iTBS) vs CS (PAS) p = 0.27; CS (PAS) vs con-
trols (PAS) p = 0.78; CS (PAS) vs controls (iTBS) p = 0.71; controls (iTBS)
vs controls (PAS) p = 0.34] (see Table 2 for details).
Remarkably, in CS patients mean baseline-normalized MEP am-
plitude was increased by about 250% immediately after PAS and by
approximately 320% when evaluated at 30 minutes after the end
of PAS, whereas after iTBS we observed no significant change of MEP
amplitude at the two time-points [CS/PAS (baseline vs T1 vs T2), CS/
iTBS (baseline vs T1 vs T2): 1 ± 0.39 vs 3.4 ± 1.5 (p = 0.02) vs 4.2 ± 1.8
(p = 0.01); 1 ± 0.4 vs 0.45 ± 0.39 (p = 0.87) vs 0.93 ± 0.38 (p = 0.8)].
In healthy subjects we observed an increase in baseline-normalized
MEP amplitude by about 73% at T1 and by about 39% at T2 after
PAS [(T1 vs baseline) vs (T2 vs baseline): (1 ± 0.49 vs 1.73 ± 0.87)
p < 0.001 vs (1 ± 0.49 vs 1.39 ± 0.68) p < 0.001] and an increase by
about 51% at T1 and by about 40% at T2 after iTBS [(T1 vs baseline)
vs (T2 vs baseline): (1.51 ± 0.62 vs 1 ± 0.4) p < 0.001 vs (1.4 ± 0.52 vs
1 ± 0.4) p < 0.001]: post hoc unpaired t-test for comparison of the
effects of the two stimulation protocols in healthy group did not
reveal any significance, that means that iTBS and PAS produce the
same facilitatory effect in baseline-normalized MEP amplitude of
controls. (Fig. 1)
When CS were compared to controls, iTBS induced a signifi-
cant increase in baseline-normalized MEP amplitude in controls, but
not in CS patients and conversely we confirmed that PAS induced
a significantly more pronounced increase of MEP amplitude in CS
when compared to control group (Fig. 1).
We found no correlation between PAS after effects/iTBS after-
effects and dystonia severity score (GDS): PAS: R = 0.92 (T1) 0.48 (T2);
iTBS: R = 0.71 (T1), 0.84 (T2) [cut-off value for a monodirectional
hypothesis 2.84].
The comparison of PAS effects in MEP amplitude changes in the
3 patients that participated in both studies did not reveal any sig-
nificant difference (T0: p = 0.74; T1: 0.93; T2: 0.95) [baseline MEP
amplitude (2 years ago vs present study) (mV): 0.67 ± 0.32 vs
0.58 ± 0.28 mV; T1 MEP amplitude: 2.2 ±1.08 vs 2.1 ± 1.09 mV; T2
MEP amplitude: 2.3 ± 1.09 vs 2.25 ± 1.13 mV, thus indicating a good
reproducibility of the PAS after-effects in CS.
Table 2
Mean baseline values (±SD) of motor thresholds and motor evoked potential (MEP)
amplitudes in each group (CS patients and controls) for each experimental session
(PAS and iTBS).
Groups RMT (% MSO) AMT (% MSO) MEP (mV)
CS
(iTBS session)
47.7 ± 5.2 35.2 ± 4.8 0.67 ± 0.27
CS
(PAS session)
46.2 ± 8.6 33.5 ± 5.5 0.6 ± 0.23
Controls
(iTBS session)
43 ± 10.6 33.9 ± 8.2 0.65 ± 0.25
Controls
(PAS session)
48.2 ± 11 35.9 ±7.8 0.55 ± 0.27
Figure 1. The bar chart illustrates the values of motor evoked potentials (MEPs), each normalized to baseline grand mean value of each group, recorded at rest in baseline
conditions, soon after and 30 minutes after the end of PAS and iTBS (in two distinct panels) in CS patients and controls; grey bars represent values for each control subject,
black bars represent values for each CS patient to show the variability of MEP amplitudes for each group. The overwritten linear plot schematically shows the time course
of the mean after-effects of PAS in CS patients and controls. Error bars represent standard deviations. *: Statistical significance when values were compared vs baseline values
of the same group (TIME effect); #: Statistical significance when the effects of PAS were compared between CS patients and controls at the same time points.





In present study we confirm our previous findings about the
effects of facilitatory PAS in CS with a pronounced enhancement of
LTP-like activity when compared with healthy subjects [18]: mean
MEP amplitude was increased by about 250% immediately after PAS
and by approximately 320% when evaluated at 30 minutes after the
end of PAS. We also show for the first time that iTBS did not induce
any LTP-like activity in Costello patients. In contrast with CS pa-
tients, the effects of the two protocols were similar in controls: both
iTBS and PAS led to an increase of about 50–70% of MEP ampli-
tude, comparable to data reported in previous studies [11,12,24].
Moreover, no differences between patients and controls were found
in baseline TMS parameters. Thus, the main finding of our study is
that PAS and iTBS induced differential after-effects in CS patients
in contrast with healthy age-matched controls.
Several hypotheses might explain present findings.
Differential after-effects of PAS and iTBS as hallmark of dystonia
A recent paper has shown that FHD patients present an in-
crease in PAS-induced plasticity and a lack of iTBS-induced one when
compared to healthy controls [21]. The authors suggested that iTBS-
induced LTP-like plasticity was reduced or absent owing to
abnormalities in intrinsic M1 circuits, whereas PAS-induced LTP-
like plasticity was considered dependent on an altered sensorimotor
integration [21]. Thus, since CS patients present mild to moderate
dystonic symptoms [19] it could be possible that the absence of iTBS-
induced plasticity and the presence of enhanced PAS-induced after-
effects could be considered a further neurophysiologic hallmark of
dystonia. Although present data are in line with those by Belvisi et al.,
further suggesting a link between dystonia and the different
behaviours of two facilitatory rTMS protocols, it should be consid-
ered that CS patients represent a special and unique patients’ cohort.
Indeed, unlike dystonic patients in which also a reduction in
intracortical inhibition was shown [25,26], CS patients are charac-
terized by a normal level of intracortical inhibition [18]. Moreover,
the increase in MEP amplitude after PAS in our patients is more pro-
nounced than that observed in focal hand dystonia patients. These
differences between CS and dystonic patients suggest that even
though it is reasonable to hypothesize that excessive neuroplasti-
city may play a mechanistic role for the development of dystonia
in CS, in analogy with patients with task specific hand dystonia [27],
more complex dysfunctional synaptic changes might be present in
CS. Moreover, we still do not know whether an abnormal process-
ing of sensory inputs is involved in the pathophysiology of dystonia
in CS as reported in focal dystonia [28,29]. Indeed, we only know
that somatosensory evoked potentials are normal in CS but for in-
stance sensory discrimination and sensorimotor integration have
never been evaluated.
Differential activation of synaptic activity by PAS and iTBS
We suggested in one of our previous papers that dystonia in CS
could be due to an altered signalling in HRAS pathways with in-
terferences in synaptic activity of basal ganglia networks [19].
Furthermore, some differences in the neuromodulatory mecha-
nisms of PAS and iTBS were already demonstrated in Parkinson’s
Disease (PD) patients in which L-dopa was able to restore abnor-
mal plasticity induced by PAS [30–32] but not the abnormal response
to iTBS [33]. Also, several lines of experimental evidence support
the hypothesis that different stimulation protocols could activate
different pathways inducing LTP. Grover and colleagues found that,
although continuous stimulation and burst stimulation are both ef-
fective in LTP induction, these procedures show a different capability
in inducing EPSPs, suggesting a differential effect of the two pro-
tocols on NMDA receptors with a different degree of participation
of L-type calcium channels [34]. Also, studies in humans have shown
that even though different protocols of rTMS produce similar changes
in MEP amplitude, the physiological bases of these effects might be
different with the involvement of different cortical circuits [35].
Differential role of HRAS in the after-effects induced by different
stimulation protocols
Recent evidence in transgenic synRas mice demonstrated that
GTPase encoded by Ras genes exerts significant morphoregulatory
effects on the dendritic phenotype as well as on the structural and
functional synaptic connectivity [36,37]: the mutation responsi-
ble for CS upregulates signal flow through this GTPase. After their
activation, NMDA receptors stimulate Ras proteins that trigger
mitogen-activated protein kinase (MAPK) pathway that, in its turn,
activates the final effectors that are critical for LTP induction: se-
lective MAPK inhibitors block synaptic LTP [38]. Although several
studies conducted on mice brain slices support the role of HRAS in
LTP induction [39,40], it is still unclear whether HRAS suppresses
[6,7,41,42] or enhances LTP [8]. Furthermore, it was recently dem-
onstrated that PAS-induced motor cortex plasticity in patients with
Neurofibromatosis type 1 (NF1) and Noonan syndrome (NS), be-
longing together with LEOPARD syndrome and Cardiofaciocutaneous
syndrome to a class of genetic syndromes linked to perturbation
of function through the Ras pathway [43], was reduced [44,45]. On
the other hand in NF-1 mouse models, a defect in CNS dopamine
was demonstrated [46] and, contemporary, it was shown that L-DOPA
administration restored defective PAS-induced plasticity in PD pa-
tients [30]. Hence, since no dopamine defect was demonstrated in
CS, it could be argued that dopamine defect in NF-1 could have in-
fluenced the results and could be one of the reason for which our
results go in an opposite direction. On the other hand, it was shown
that carrying a mutated neurofibromin with gain of function mu-
tation in the RAS-MAPK pathway leads to a decrease rather than
increase of LTP [40,41]. Hence, the discrepancy between our results
about PAS and iTBS-induced plasticity in CS and results about plas-
ticity in Noonan Syndrome and NF-1 could be due, in our opinion,
to the different sites of mutation in the different pathologies. For
example neurofibromin is the altered multidomain Ras-activating
protein in NF-1, Ras is also stimulated by membrane growth factor
tyrosine kinase receptors acting through Sos and ShP2 (targets of
mutation in Noonan syndrome) [47]. Moreover, due to the com-
plexity of LTP phenomena that involve multiple electrophysiological
components of neurons, it was shown that, in NF1 mice brain slices,
theta burst stimulation (TBS) effects were reduced while high fre-
quency stimulation (HFS) effects were normal [48]. Furthermore,
although LTP induced by high-frequency stimulation (100 Hz) is en-
hanced in HRAS knock out mice [6], it was shown that low-frequency
(5 Hz) stimulation-induced LTP is normal suggesting that the in-
volvement of HRAS-dependent signalling pathways in LTP may be
highly dependent on the pattern of synaptic stimulation [8,22]. Based
on these assumption it could be argued that HRAS-dependent per-
turbations of intracellular signalling could affect some key factors
in the capability of the different stimulation protocols to induce plas-
ticity, probably by influencing the properties of the post-synaptic
neuron [22,41,42].
After considering the neurophysiologic differences between CS
patients and FHD patients, the central role of HRAS in pathophysi-
ology of CS and the experimental evidence of an involvement of
HRAS in LTP highly dependent on the pattern of synaptic stimula-
tion used, although the non invasive nature of rTMS studies at the
system level makes unlikely a strict correspondence between mecha-
nisms underlying in vivo LTP-like plasticity and those underlying









experimental LTP [49], our data suggest that HRAS-dependent sig-
nalling pathways could differently affect in vivo LTP-like phenomena
induced by iTBS and PAS. However, despite we studied approxi-
mately 1% of the world CS population [50], our study presents the
main limitation of the small number of included CS patients and
further studies are needed to further elucidate the role of HRAS sig-
nalling in synaptic plasticity.
Conclusions
The presence of differential after-effects induced by PAS and iTBS
in this cohort of CS could represent not only a complex neurophysi-
ologic marker of dystonia, but could also support the hypothesis of
subtle differences in the mechanisms of action of PAS and iTBS in
humans and, at last, suggest their different dependence on HRAS
signalling pathways.
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The Level of Cortical Afferent Inhibition in Acute Stroke
Correlates With Long-Term Functional Recovery
in Humans
Vincenzo Di Lazzaro, MD; Paolo Profice, MD; Fabio Pilato, MD; Fioravante Capone, MD;
Federico Ranieri, MD; Lucia Florio, MD; Cesare Colosimo, MD; Emanuele Pravatà, MD;
Patrizio Pasqualetti, PhD; Michele Dileone, MD
Background and Purpose—Using transcranial magnetic stimulation, we investigated short-interval intracortical inhibition
and short-latency afferent inhibition in acute ischemic stroke.
Methods—We evaluated short-interval intracortical inhibition and short-latency afferent inhibition in the affected
hemisphere and unaffected hemisphere in 16 patients and correlated electrophysiological parameters with outcome at 6
months.
Results—Affected hemisphere short-latency afferent inhibition was significantly reduced in patients, and short-latency
afferent inhibition level correlated with functional outcome.
Conclusions—Reduced afferent inhibition in acute stroke correlates with long-term recovery. (Stroke. 2012;43:250-252.)
Key Words: GABA ! transcranial magnetic stimulation
Changes in gamma-aminobutyric acid (GABA)-ergic ac-tivity in perilesional cortex after stroke have a central
role in recovery.1 Inhibitory circuits of human cerebral cortex
can be evaluated using paired–pulse transcranial magnetic
stimulation, short-interval intracortical inhibition (SICI), or
by coupling peripheral nerve stimulation with transcranial
magnetic stimulation in short-latency afferent inhibition
(SAI).2 Both inhibitory phenomena are mediated by inhibi-
tory interneurons that use GABAA receptors, but different
receptor subtypes are involved in SICI and SAI.2
We investigated SICI and SAI in acute stroke and evalu-
ated the correlation between the level of cortical inhibition
and functional outcome at 6 months.
Methods and Patients
Sixteen patients (mean age, 66.8!13.4 years) with first-ever stroke
were recruited. Acute-phase evaluation was based on the National
Institutes of Health Stroke Scale. Outcome at 6 months was assessed
using modified Rankin Scale (mRS). This study was performed
according to the Declaration of Helsinki and was approved by the
local ethics committee. Patients gave their informed consent before
participation.
Patients underwent brain magnetic resonance imaging. Seven
patients had a subcortical stroke, whereas 9 patients showed cortical
and subcortical involvement. To evaluate whether SAI changes were
correlated with structural abnormalities of cholinergic systems, we
estimated the damage extent of pathways emanating from nucleus
basalis of Meynert: medial pathway, Capsular Lateral pathway, and
Perisylvian Lateral pathway.3 For further details, see Supplemental
Methods and Supplemental Figure I (http://stroke.ahajournals.org).
Magnetic Stimulation
We evaluated active motor threshold and resting motor threshold,
amplitude of motor-evoked potentials (MEP), SICI at 2 ms inter-
stimulus interval, and SAI at interstimulus intervals from N20
latency plus 2, 3, and 4 ms. We evaluated both affected hemispheres
(AH) and unaffected hemispheres (UH).
Because it has been suggested that a change in the slope of
input–output curve may influence the amount of cortical inhibition,4
we also obtained AH input–output curve using increasing stimulus
intensities and evaluated whether there was a correlation between
slope of input–output curves and amount of AH-SAI.
Data obtained in patients were compared with those obtained in 13
healthy subjects (mean age, 70.4!11 years).
Statistical Analysis
Comparison between AH and UH was performed by means of paired
t-test, after checking frequency distributions and, eventually, trans-
formed raw values, to achieve a better fit to gaussianity and a
reduction of biasing effects of outliers (such as for MEP values).
Comparisons of stroke patients versus healthy subjects were per-
formed by means of t-test for independent samples.
Associations between electrophysiological findings and clinical
outcome (mRS at 6 months) were assessed by means of nonpara-
metric Spearman’s rho. The potential effect of the lesion site on mRS
was assessed with Mann-Whitney U test. Electrophysiological mea-
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sures associated with clinical outcome were further investigated through
partial correlation analysis. More specifically, the correlation between
AH-SAI and mRS-6-months was controlled for baseline National
Institutes of Health Stroke Scale with the following formula:
Here, the left term indicates partial correlation between SAI and
mRS, controlling for National Institutes of Health Stroke Scale, and
the right term comprises the usual bivariate nonparametric correla-
tions. This measure, after the appropriate transformation, follows a
t-distribution with (n!3) degrees of freedom.
Correlation between AH-SAI and the recruitment slope (indexed by
the linear increase of MEP amplitude with respect to stimulation
increase) was evaluated with Spearman’s rho. Because stroke-induced
functional changes in cortical excitability may be influenced by stroke
location and distribution,5 we evaluated the effect of lesion site (sub-
cortical or cortical–subcortical) on SAI using Mann-Whitney U test.
Nonparametric Spearman’s ! was used to correlate AH-SAI with
percentages of lesional voxels in cholinergic pathways.
Significance levels were adjusted according to Bonferroni proce-
dure to control the risk of "-inflation.
Results
Results are summarized in Figure. AH-SAI and AH-MEP
amplitude were lower than corresponding UH and control
values.
No evidence of association between electrophysiological
parameters and stroke severity in the acute phase was found
(consistently P"0.05). Looking at correlations with clinical
status at 6 months, the only significant associations were
found with AH-SAI (Table).
When the effect of AH-SAI on mRS was adjusted for the
confounding effect of baseline clinical status (National Insti-
tutes of Health Stroke Scale at T0), the nonparametic partial
correlation remained significant (rho#0.66; P#0.016), sug-
gesting its relevance even equalizing for baseline clinical
status.
There was no correlation between AH-SAI and either slope
of the input–output curve (Spearman’s rho#0.12; P#0.676)
or site of the lesion (Mann-Whitney U, P#0.958). Also, there
was no correlation between site of the lesion and recovery at
6 months (Mann-Whitney U, P#0.99).
Involvement of cholinergic pathways was limited (Supple-
mental Table I), and there was no correlation between
AH-SAI and either percentage of lesional voxels of medial
pathway (!#!0.39; P#0.52), lateral cholinergic pathways
Figure. Electrophysiological findings in patients and controls. Control subjects’ and patients’ (UH and AH) individual values and 95%
CIs of resting motor threshold (RMT) and active motor threshold (AMT), motor evoked potential (MEP) amplitude (t test applied after
appropriate log-transformation), N20 amplitude, short-latency afferent inhibition (SAI), and short-latency intracortical inhibition (SICI).
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(!!"0.47; P!0.264), and lateral perforant pathway
(!!"0.43; P!0.376) or percentage of lesional voxels in the
3 pathways considered together (Spearman’s !!"0.5;
P!0.17).
Discussion
We report for the first time a suppression of afferent inhibi-
tion in acute stroke. AH-SAI level was correlated with
recovery at 6 months.
SAI is produced by afferent inputs, and central cholinergic
pathways are involved in SAI2; thus, a lesion of these circuits
might explain its reduction. However, the absence of consis-
tent sensory deficits and/or abnormalities of N20 wave of
somatosensory evoked potentials, the limited involvement of
cholinergic pathways, and the absence of any correlation
between involvement of cholinergic pathways and level of
SAI, make this hypothesis unlikely.
We speculate that SAI suppression might be produced by
functional changes in central inhibitory circuits.2 Because
SAI is probably mediated by the "5-subunit,2 we suggest that
its suppression might be related to a reduction of activity
related to this subunit. Interestingly, a recent experimental
study showed that pharmacological antagonization of "5-
subunit activity promotes functional recovery after stroke.1
Long-term potentiation can be induced in motor cortex by
stimulation of sensory cortex,6 and it has been proposed
that long-term potentiation produced by sensory inputs
might promote cortical reorganization after a lesion.7 Thus,
it can be speculated that reduced SAI level could enhance
sensory stimuli-related long-term potentiation phenomena
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Table. Bivariate Correlation Between Electrophysiological
Findings and Clinical Recovery (modified Rankin Scale Score at
6 months)
Spearman’s ! Corrected P Value
RMT, UH "0.04 #0.90
RMT, AH "0.07 #0.90
AMT, UH 0.37 #0.90
AMT, AH 0.24 #0.90
MEP amplitude, UH 0.29 #0.90
MEP amplitude, AH 0.13 #0.90
SAI, UH 0.29 #0.90
SAI, AH 0.68 0.03
SICI, UH 0.54 0.3
SICI, AH 0.10 #0.90
RMT indicates resting motor threshold; UH, unaffected hemisphere; AH,
affected hemisphere; AMT, active motor threshold; MEP, motor-evoked poten-
tial; SAI, short-latency afferent inhibition; SICI, short-interval intracortical
inhibition.
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a b s t r a c t
Background: Significant changes in neurophysiological and clinical outcomes in chronic stroke had been
reported after tDCS; but there is a paucity of data in acute stroke.
Objective:We aimed to evaluate whether a tDCS-induced modulation of primary motor cortex excitability
in patients with acute stroke enhances motor recovery associated with rehabilitation and induces dif-
ferential neuroplasticity.
Methods: We conducted two experiments in acute stroke patients. In experiment 1 (14 patients), we
tested the immediate effects of bilateral tDCS alone as compared to sham tDCS on recovery. Experiment 2
(20 patients) was designed to assess effects of bilateral tDCS delivered together with constraint-induced
movement therapy (CIMT). In this experiment, we included a longer follow-up (3 months) and
measured, in addition to the same clinical outcomes of experiment 1, changes of motor cortex excitability
and the amount of promoted LTP-like activity.
Results: Despite the expected improvement at 1 week, none of the clinical measures showed any
different modulation in dependence of CIMT and tDCS. On the neurophysiological assessments, on the
other hand, the Real_tDCS group, compared to Sham_tDCS group, showed a reduction of inter-
hemispheric imbalance when considering the differences of motor evoked potential between both 3-
month and 1 week follow up (P ¼ 0.007) and three month and baseline (P ¼ 0.015).
Conclusions: Despite the lack of additional clinical changes, real bilateral tDCS, together with CIMT,
significantly reduces inter-hemispheric imbalance between affected and unaffected hemispheres. These
findings may shed light on plasticity changes in acute stroke and its potential impact in chronic phases.
! 2014 Elsevier Inc. All rights reserved.
Introduction
In recent years, several small studies have reported positive
effects of non-invasive cortical stimulation, in the form of re-
petitive transcranial magnetic stimulation (rTMS) or trans-
cranial direct current stimulation (tDCS), to enhance recovery in
patients with acute or subacute stroke [1e3]. However, it is still
unknown whether these interventions will be useful in the
clinical setting. Neuromodulation techniques can induce long-
lasting changes in the excitability of the synapses in motor
cortical areas in a manner which might be biologically similar
to the long-term potentiation/depression (LTP/LTD) phenomena
described at cellular level [4]. LTP/LTD are important for
learning and memory and are likely involved in reacquisition of
skill after stroke.
Considering that, in the acute phase of stroke, animal and
in vitro models have showed that various markers of plasticity are
shown to be at higher levels both in perilesional territories of
affected hemisphere (AH) [5,6] and remotely in the contralateral
unaffected hemisphere (UH) [7], it is reasonable that, during this
phase, the effects of neuromodulatory therapy might be
maximized.
One of the most influential models of stroke recovery is based
on the inter-hemispheric rivalry or competition hypothesis: the
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AH becomes doubly disabled, both by its own damage and by the
increased hindering output from UH, no longer inhibited by the
hypo-functioning AH [8,9]. Although other possible explanations
may account for the imbalance of excitability between the two
hemispheres (i.e. vicariation of the AH), the inter-hemispheric
competition has been exploited so far as rationale by most of
the neuromodulatory interventions aimed at improving stroke
motor recovery [41]. According to this model, recovery can be
favored by increasing the cortical excitability on the affected side
and/or reducing the excitability of the unaffected side.
It may then be the case that the bilateral application of tDCS over
themotor cortices, with anodal tDCS over the AH and cathodal tDCS
over the UH, results in a useful strategy to induce an additive effect
compared to unilateral stimulation [10e12].
We designed two experiments to assess whether tDCS-induced
bihemispheric modulation in acute stroke patients (tested within
48e96 h of stroke) would modify neuroplasticity and clinical out-
comes. In the preliminary small double-blind, randomized, placebo
controlled experiment (experiment 1) we evaluated the short-term
effects of bilateral tDCS alone on recovery. Since this experiment
was negative, we designed another experiment as to assess further
plasticity and long-term effects by combining tDCS with constraint-
induced movement therapy. Our initial hypothesis was that active
tDCS would induce larger motor gains and enhanced neuro-
plasticity as compared to sham tDCS.
Given the two main techniques of non-invasive brain stimula-
tion, we chose tDCS. Although these two techniques seem to have a
final common effect on neuroplasticity, their effects are mediated
by different mechanisms of action. A recent experimental study has
shown that direct current stimulation applied to rat brain slices has
a direct effect on the amount of LTP that can be induced by repet-
itive stimulation [13]. This is increased by anodal and reduced by
cathodal DCS. In analogy with these experimental data, it can be
speculated that in the intact human brain, tDCS, even though via
subthreshold modulation, can enhance the propensity of the cortex
to undergo LTP-like plasticity after rTMS [14,15]. This latter
approachmeans that tDCS exerts his effect especially when coupled
with other interventions, thus it might be useful to promote
relearning of skills when associated with motor rehabilitation,
given also that tDCS is feasible simultaneously with behavioral
therapies [16]. Therefore, by combining non-invasive brain stimu-
lation and motor training/learning it should be possible to increase
the modulatory effects on the motor neural network and thus in-
crease clinical gains.
We conducted a detailed neurophysiological and clinical
assessment. In fact, given the possibility that the assessment of the
clinical outcome would not be sensitive enough to all the aspects of
the effects induced by tDCS, we evaluated also changes in motor
cortex excitability of both hemispheres.
Along this line, we recently showed that the level of LTP-like
activity promoted by intermittent theta burst stimulation (iTBS),
a robust form of rTMS, delivered to the affected hemisphere
(AH) during the acute phase of human stroke correlates with
long-term functional recovery [17]. Similarly, suppressive rTMS
of the unaffected hemisphere (UH) resulted in the reduction of
the AH motor threshold that correlated with recovery [18]. Thus,
the neuroplasticity response to neuromodulatory protocols in
the acute phase of stroke over both hemispheres is a parameter
that might be useful as a surrogate marker of recovery.
Accordingly, in this experiment, we also evaluated whether five
consecutive days of bilateral tDCS could increase the propensity
of the hemispheres to undergo LTP-like plasticity. We used iTBS,
which is able to promote LTP-like activity lasting up to 1 h [19],




Patients with a history of first ischemic cerebral infarct admitted
to the Stroke Unit were enrolled in the study. Inclusion criteriawere:
(1) Age 18e90; (2) Clinical first ever ischemic cerebrovascular ac-
cident e confirmed by MRI; (3) Acute phase of stroke (treatment
was started 48e96 h after the stroke onset).
Exclusion criteria: (1) Pre-stroke disability; (2) Any substantial
decrease in alertness, language reception, or attention that might
interfere with understanding instructions for motor testing; (3)
Excessive pain in any joint of the paretic limb; (4) Contraindications to
single-pulse TMS, such as metal head implants; (5) Advanced liver,
kidney, cardiac, or pulmonary disease; (6) Coexistent neurological or
psychiatric disease (including epilepsy) as to decrease number of
confounders; (7)Historyof significant alcoholordrug abuse; (8)Useof
neuropsychotropicdrugs, suchasantidepressantsorbenzodiazepines.
The study was approved by the local Ethics Committee. For each
experiment,patientswere randomized to real or shamtDCStreatment
through a block randomization stratification approach (Table 1). This
approach ensured that both groups had similar motor impairment.
Fourteen patients were recruited for the first experiment, 7
patients underwent real bilateral tDCS and 7 patients underwent
sham tDCS.
Twenty patients were recruited for the second experiment, 10
patients underwent real bilateral tDCS and 10 patients underwent
sham tDCS.
Details of demographic and clinical features of each patient are
presented in Table 2.
Transcranial direct current stimulation
Direct current was transferred by a saline-soaked pair of surface
sponge electrodes (35 cm2) and delivered by a specially developed,
battery-driven, constant current electrical stimulator (Eldith DC-
Stimulator, Germany). Real/sham tDCS was applied for five
continuous days, for 40-min per day. The investigators who applied
real/sham tDCS were kept blind to the intervention by using the
pre-programmed stimulation mode in the stimulator settings.
Real tDCS
Participants received tDCS over the primary motor cortex








Mean SER Mean SER Test value (t) P value
Age 71.71 5.254 66.43 5.956 !0.666 0.518
Onset_Days 2.71 0.421 2.57 0.812 !0.156 0.878
NIHSS admission 7.00 1.345 7.29 2.008 0.118 0.908
mRS admission 3.57 1.134 3.57 0.202 0.000 1.000






Mean SER Mean SER Test value (t) P value
Age 68.80 3.681 60.80 5.101 !1.272 0.220
Onset_Days 3.40 0.452 3.10 0.567 !0.414 0.684
NIHSS admission 5.90 0.657 5.80 0.940 !0.087 0.932
mRS admission 3.80 0.200 3.30 0.260 !1.523 0.145
Weak side (R/L) 6R/4L 2R/8L




(saline-soaked sponge electrode e 35 cm2) was placed over the
primary motor cortex of the AH (C3 or C4 (10/20 international EEG
system) depending on the lesion side). The excitability-diminishing
cathode electrode was placed over the contralateral primary motor
cortex of the UH (C3/C4 depending on the lesion side). This
montage allows a simultaneous inhibition of the M1 activity in the
UH and stimulation in the affected M1. The stimulation parameters
were: intensity of 2 mA for 40 min with a current density of
0.057 mA/cm2 (10 s of fade-in and fade-out). We used the same
montage as tested by Bolognini et al. and ensured a minimal dis-
tance between electrodes of at least 7 cm [20].
Sham tDCS
The same montage and stimulation parameters were employed
for sham stimulation, however, current was only applied for 30 s to
induce the slight tingling sensation that some subjects report
experiencing during tDCS stimulation. This method of sham stim-
ulation has been shown to be reliable [21].
Furthermore, for both real and sham stimulation current in-
tensity was gradually increased (at the beginning of the session)
during 10 s and decreased (at the end of the session) also during
10 s to diminish its perception.
Experiment 1: short term clinical effects of tDCS
All patients underwent a standardized protocol of rehabilitation
based on physical therapy (Fig. 1 Top Panel). An evaluator, blinded
to the treatment, assessed the effects of the interventions before the
beginning of treatment (baseline assessmentet0) and 1 week after
(2 days after the end of the treatmentet1) using the following
validated measures sensitive to hand function changes: (i) Action
Research Arm Test (ARAT); (ii) 9 Hole Peg Test (9HPT); (iii) Hand-
grip strength [22]; (iv) Motor Activity Log Rating Scale (MAL) [23];
(v) Score on the National Institutes of Health stroke scale (NIHSS)
[24,25]; (vi) modified Rankin Scale score to assess stroke-related
disability; (vii) Adverse event monitoring and reporting.
Experiment 2: short- and long-term clinical and electrophysiological
effects of tDCS associated with constraint-induced movement
therapy
Subjects enrolled in experiment 2 were treated with the asso-
ciation of physical rehabilitation with real/sham bilateral tDCS. All
the subjects underwent constraint-induced movement therapy
(CIMT), while they were randomized in two groups that received
either real or sham bilateral tDCS (Fig. 1 Bottom Panel).
Along 5 days of physical rehabilitation, real/sham tDCS was
applied for 40-min during themotor training session, starting 5min
before the beginning of the session.
CIMT was administered for five days by a trained therapist, who
was not involved in the pre-post evaluations. The therapy consisted
of the association of training tasks designed according to behavioral
“shaping” technique while wearing, on the non-paretic hand, a
resting splint secured in a sling, which hindered hand and finger
activity (SkiL-Care Rigid Palm Padded Mitt; AliMed, Inc, Dedham,
Massachusetts). The splint had to beworn for at least 90% of waking
Table 2
Demographic and clinical features of patients randomized in the two groups.
Patient
no.










Experiment 1 real tDCS 1 F 79 3 No R 10 4 Sc MCA LAA
2 M 37 1 No L 3 3 C/Sc MCA CE
3 M 70 1 No R 5 4 Sc MCA LAA
4 F 82 1 No L 17 4 C/Sc MCA LAA
5 M 70 4 No R 9 4 C/Sc IC LAA
6 M 54 4 No L 6 3 C/Sc IC LAA
7 M 73 1 No L 1 3 Sc PCA CE
sham tDCS 8 M 71 2 Yes L 4 4 C/Sc MCA CE
9 M 80 4 Yes L 2 1 C/Sc MCA LAA
10 F 77 2 No L 8 4 C/Sc ACA/MCA CE
11 M 80 3 No R 6 4 C/Sc MCA CE
12 M 78 2 No R 9 4 Sc MCA LAA
13 F 41 3 No R 13 4 C/Sc IC OE
14 F 75 2 Yes L 7 4 Sc MCA LAA
Experiment 2 real tDCS 1 F 51 4 No L 9 4 Sc MCA LAA
2 M 28 4 No R 4 2 Sc MCA UE
3 M 68 7 No L 6 3 C/Sc ACA/MCA LAA
4 F 53 3 Yes L 7 4 C/Sc MCA LAA
5 F 74 3 No L 2 3 Sc MCA SVO
6 M 83 2 No L 3 2 C/Sc IC LAA
7 M 78 4 No R 6 4 C/Sc ACA/MCA LAA
8 M 56 1 Yes L 12 4 C/Sc MCA LAA
9 M 53 1 No L 5 4 C/Sc MCA LAA
10 F 64 2 No L 4 3 Sc MCA CE
sham tDCS 11 M 53 1 Yes L 6 4 Sc MCA LAA
12 F 66 4 No L 5 4 C/Sc MCA/PCA CE
13 M 69 2 Yes L 7 4 C/Sc MCA LAA
14 M 77 4 No R 6 4 C/Sc MCA CE
15 F 77 4 No L 2 2 Sc MCA LAA
16 M 54 4 No R 7 4 C/Sc ACA CE
17 M 63 4 No R 10 4 Sc VB LAA
18 M 83 2 No R 4 4 C/Sc MCA LAA
19 F 86 3 Yes R 6 4 Sc MCA CE
20 M 60 3 No R 6 4 C/Sc IC LAA
tDCS, transcranial direct current stimulation; M, male; F, female; R, right; L, left; NIHSS, NIH Stroke Scale; mRS, modified Rankin Scale; C, cortical; Sc, subcortical; ACA, anterior
cerebral artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; IC, internal carotid artery; VB, vertebrobasilar; TOAST, Trial of Org 10172 in Acute Stroke
Treatment; LAA, large artery atherosclerosis; CE, cardioembolism; SVO, small vessel occlusion e lacunar stroke; OE, other determined etiology; UE, undetermined etiology.




hours [20,26]. During the 5 days of the treatment period, all pa-
tients received 1.5 h per day of training of the affected arm in the
laboratory [27]. Training tasks were designed to force an intensive
use of the paretic extremity, while requiring a progressive
improvement of the quality of movement [28]. Participants were
supervised by study staff who helped to direct them throughout the
entire period the hand mitt was worn. Nine different shaping tasks
were used during this 1.5-h period, which included buttoning a
shirt, pouring water, and folding towel.
As part of experiment 2, patients were evaluated at baseline (t0),
one week after (t1) and at 3-month follow-up. In these patients, we
also explored motor cortex excitability of the AH and UH and the
effects of the treatment (Bilateral tDCSþ CIMT) on the propensity of
the motor cortex of the AH to undergo LTP-like phenomena pro-
moted by using iTBS [19].
Transcranial magnetic stimulation measurements of brain
excitability (experiment 2)
Magnetic stimulation was performed with a high-power Mag-
stim 200 (MagstimCo., Whitland, Dyfed). A figure-of-eight coil with
external loop diameters of 9 cm was held over the motor cortex at
the optimum scalp position to elicit MEPs in the contralateral first
dorsal interosseous muscle (FDI). The induced current flowed in a
postero-anterior direction.
We evaluated the threshold and amplitude of MEPs of AH and
UH. The resting motor threshold (RMT) was defined as the mini-
mum stimulus intensity that produced a liminal MEP (about 50 mV
in 50% of 10 trials) at rest. The active motor threshold (AMT) was
defined as the minimum stimulus intensity that produced a liminal
MEP (about 200 mV in 50% of 10 trials) during isometric contraction
of the tested muscle. The MEP amplitude was evaluated using a
stimulus intensity of 120% RMT with the muscle at rest. Subjects
were given audio-visual feedback of the electromyographic (EMG)
signal at high gain to assist in maintaining complete relaxation;
trials contaminated by EMG activity were discarded. Ten data
sweeps were collected, and the peak-to-peak amplitude of the
MEPs was calculated.
Intermittent theta burst stimulation
At t0 (baseline), t1 (1 week later) and at t2 (3-month follow-up),
iTBS was delivered to the AH over the motor cortex “hot spot” for
MEPs in the contralateral FDI muscle using a MagPro stimulator
(Medtronic A/S Denmark) connected to a figure-of-eight coil (MCF
B65). The magnetic stimulus had a biphasic waveform with a pulse
width of about 280 ms and a maximum magnetic field strength of
1.5 T. The initial direction of the current induced in the brain was
anterior to posterior. The exploited stimulation intensity was set to
the 80% of AMT. We used the iTBS protocol in which 10 bursts of
high frequency stimulation (3 pulses at 50 Hz) are applied at 5 Hz
every 10 s, for a total of 600 pulses.
We evaluated the effects of iTBS, applied overM1 of AH, onMEPs
amplitude elicited stimulating both hemispheres. MEP amplitude
was evaluated before and after iTBS using the same stimulus in-
tensity (120% RMT measured under baseline conditions).
Statistical analysis
Analyses were performed using SPSS 19 statistical software
(IBM). The analysis of experiment 1 evaluated whether the clinical
outcome at 1 week was influenced by neuromodulation alone
(Real_tDCS vs Sham_tDCS).
Figure 1. Experimental design. Top panel: Experiment 1 is a small double-blind, randomised, placebo controlled experiment to evaluate the short-term effects of bilateral tDCS on
recovery. Patients, recruited and treated 48e96 h after the stroke onset, underwent real/sham tDCS (2 mA, current density 0.057 mA/cm2), applied for five continuous days, for 40-
min per day. The effect of the stimulation was assessed through clinical scales (NIHSS ¼ National Institutes of Health stroke scale, mRS ¼ modified Rankin Scale, ARAT ¼ Action
Research Arm Test, GRIP ¼ Handgrip strength, MAL (AOU) ¼Motor Activity Log Rating Scale e Amount of Use, MAL (QOM) ¼Motor Activity Log Rating Scale e Quality of Movement,
NHPT ¼ 9 Hole Peg Test) administered before the beginning of treatment (baseline assessment e t0) and 1 week after (2 days after the end of the treatment e t1). Bottom panel:
Subjects of experiment 2 underwent constraint-induced movement therapy (CIMT), while they were randomized in two groups that received either real or sham bilateral tDCS
(2 mA, current density 0.057 mA/cm2). Along 5 days of physical rehabilitation, real/sham tDCS was applied for 40-min/day during the motor training session, starting 5 min before
the beginning of the session. Patients. In these patients, the same clinical scales of experiment 1, AH and UH motor cortex excitability and the effects of the treatment on the
propensity of the motor cortex of the AH to undergo LTP-like phenomena promoted by iTBS, were evaluate at baseline (t0), one week after (t1) and at 3-month follow-up.




The analysis of experiment 2 addressed the effects of tDCS
administration as add-on to CIMT at 1 week and up to three months
on: i) clinical outcome; ii) brain excitability and inter-hemispheric
balance; iii) iTBS-promoted cortical plasticity.
When only a value for each cell of the design was available, we
used the analysis of variance or, if data did not fulfill the underlying
assumptions, the ManneWhitney test. By applying a General Esti-
mating Equation (GEE) we have been able to exploit the several
MEP values available for each patient in each cell of the design.
Since MEPs were registered consecutively, we chose the autore-
gressive (lag ¼ 1) working correlation within subjects [22].
In order to assess whether tDCS can modify the inter-
hemispheric excitability asymmetry we decided to emphasize
inter-hemispheric differences by computing the Laterality Index
(LI), parameter that has been widely tested in stroke patients by





LI ranges from #1 to þ1 and the bigger the distance from 0, the
higher is the inter-hemispheric imbalance. Positive values denote
higher excitability of the UH.
In healthy subjects, LI tends to 0, with slightly difference due to
the hemisphere dominance. In stroke patients it is considerably
positive and, according to the inter-hemispheric competition
model, tend to return to 0 in well recovered subjects [30]. We
studied the LI differences between the two groups (Real_tDCS and
Sham_tDCS e experiment 2). In particular, we computed LI differ-
ences normalized for the LI of second term of the difference
(t1 # t0_norm, t2 # t1_norm and t2 # t0_norm). For instance,
t1 # t0_norm corresponds to (LIt1 # LIt0)/LIt0.
Data distribution was studied by means of Kolmogorove
Smirnov test and proper transformations to better approximate
Gaussianity and reduce outliers were applied when useful. The
significance level was set to P < 0.05. The alpha-inflation due to




Experiment 1 e For each clinical measure (NIHSS, mRS, ARAT,
NHPT, NIHSS, MAL (AOU), MAL (QOM)) we computed a repeated
measure ANOVA with Time as within subject factor (2 levels:
baseline, 1 week) and tDCS (two levels: real and sham) as between
subject factors. tDCS had no effect on clinical outcome (tDCS and
the tDCS by Time interaction: P > 0.200 consistently). We
confirmed the expected and well-known time-related clinical
improvement (factor Time P < 0.001 for all the measures consid-
ered) (Table 3).
Experiment 2 e The repeated measure ANOVA with Time as
within subject factor (3 levels: base, 1 week, 3 months) and tDCS (2
levels: real and sham) as between subject factor showed the
absence of tDCS effect on clinical outcome (factor tDCS and tDCS by
Time interaction: P > 0.050 consistently).
Cortical excitability e experiment 2
The aim of the analysis was to checkwhether therewas a change
of brain excitability across hemispheres, time and groups.
The two groups (real tDCS vs. sham tDCS) had no different
excitability at baseline (t0), as demonstrated by the lack of tDCS
factor effect (Wald chi-square ¼ 0.352, df ¼ 1, P ¼ 0.553) and of
Hemisphere by tDCS interaction (Wald chi-square ¼ 066, df ¼ 1,
P ¼ 0.797). The inter-hemispheric excitability imbalance, well-
known in acute stroke, was confirmed in both groups by the pres-
ence of a main effect of Hemisphere (Wald chi-square ¼ 15.334,
df ¼ 1, P < 0.001).
The further step was to compare the excitability of the two
groups (real tDCS and Sham tDCS) along the time-course of the
investigation computing a GEE model with Patient as “Subject” (or
cluster) variable, MEP values as dependent variable and Hemi-
sphere (AH and UH), Time (t0, t1, t2) and tDCS (Real and Sham) as
predictors. The presence of a significant triple interaction Time by
Hemisphere by tDCS (Wald chi-square ¼ 31.652, df ¼ 7, P < 0.001)
showed that the inter-hemispheric balance of excitability is differ-
ently modulated along time accordingly with tDCS exposure (real
tDCS and Sham tDCS) (Fig. 2A).
In the context of the effect of tDCS on the inter-hemispheric
balance, the Real_tDCS group, compared to the Sham_tDCS group,
showed a reduction of LI when considering both t2 # t1_norm
(P ¼ 0.007) and t2 # t0_norm (P ¼ 0.015). No differences between
groups were found considering t1 # t0_norm (Fig. 2B).
In summary, the main effect of tDCS was the reduction of inter-
hemispheric imbalance at 3 months of follow-up (Table 4).
LTP/LTD-like changes promoted by iTBS e experiment 2
We wanted to evaluate whether the addition of tDCS to a CIMT
protocol can change the amount of LTP of the AH and of LTD of UH
promoted by iTBS applied over the AH. We computed a GEE model
with Patient as “Subject” (or cluster) variable, MEP values as
Table 3
Clinical data for the four groups at multiple time points (mean and standard error of the mean e SER).
Experiment 1 Experiment 2
tDCS_sham tDCS_real tDCS real tDCS sham
t0 t1 t0 t1 t0 t1 t2 t0 t1 t2
Mean SER Mean SER Mean SER Mean SER Mean SER Mean SER Mean SER Mean SER Mean SER Mean SER
NIHSS 7.00 1.35 3.71 0.97 7.29 2.01 4.00 0.85 5.80 0.94 2.40 0.31 1.33 0.44 5.90 0.66 3.80 0.65 1.89 0.54
mRS 3.57 0.43 3.00 0.49 3.57 0.20 3.00 0.38 3.30 0.26 2.40 0.37 0.44 0.29 3.80 0.20 3.10 0.46 1.11 0.35
ARAT 25.57 9.99 35.00 9.57 23.29 6.90 34.29 7.91 28.00 7.08 47.20 4.93 56.44 0.44 28.00 6.13 45.00 5.64 54.67 1.67
GRIP 0.19 0.12 0.34 0.12 0.26 0.11 0.37 0.13 0.17 0.10 0.38 0.09 0.67 0.12 0.22 0.09 0.32 0.10 0.67 0.13
MAL (AOU) 1.86 0.70 2.59 0.79 0.85 0.27 1.60 0.45 1.48 0.46 2.78 0.53 4.63 0.14 1.17 0.31 2.53 0.42 4.45 0.26
MAL (QOM) 2.00 0.74 2.54 0.78 0.89 0.27 1.56 0.43 1.63 0.48 2.85 0.53 4.53 0.16 1.39 0.39 2.58 0.40 4.37 0.23
NHPT 0.25 0.12 0.37 0.15 0.09 0.06 0.21 0.12 0.12 0.06 0.36 0.09 0.77 0.04 0.18 0.08 0.38 0.10 0.74 0.07
NIHSS¼National Institutes of Health stroke scale, mRS¼modified Rankin Scale, ARAT¼ Action Research Arm Test, GRIP¼ handgrip strength, MAL (AOU)¼Motor Activity Log
Rating Scale- Amount of Use, MAL (QOM) ¼ Motor Activity Log Rating Scale e Quality of Movement, NHPT ¼ 9 Hole Peg Test.





dependent variable and Hemisphere (AH and UH), tDCS (Real and
Sham), Time (t0, t1, t2) and TBS (Pre-TBS and Post-TBS) as
predictors.
The presence of a significant Hemisphere by Time by TBS by
tDCS interaction (Wald chi-square ¼ 41.472, df ¼ 14, P < 0.001)
suggests that the effect of TBS on each hemisphere differently
changes along time in the two groups.
Once the GEEmodel with Hemisphere (AH and UH), Time (t0, t1,
t2) and TBS (Pre-TBS and Post-TBS) as predictors was applied
separately for each group, we found a significant Hemisphere by
Time by TBS interaction only for the Real_tDCS group (Real_tDCS:
Wald chi-square ¼ 28.870, df ¼ 7, P < 0.000; Sham_tDCS: Wald chi-
square ¼ 6.350, df ¼ 7, P ¼ 0.499). Therefore, in other words, the
“Real tDCS” supports a different modulation of TBS effects across
Hemispheres and Time. The visual inspection of the curves (Fig. 3)
suggests that at t1 iTBS produced both greater increase of AH
excitability and decrease of UH excitability in patients exposed to
Real_tDCS.
Finally, the post-iTBS study of LI suggests that real tDCS de-
creases inter-hemispheric imbalances compared to Sham_tDCS
(t2 " t1_norm: ManneWhitney test, P ¼ 0.042, not corrected for
multiple comparisons) (Fig. 4). In other words, tDCS improves
baseline inter-hemispheric balance and also TBS effects on inter-
hemispheric balancing.
Discussion
Our first important conclusion, from the assessment of all clin-
ical instruments in both experiments, is that, in acute stroke, our
strategy of tDCS does not result in significant clinical improve-
ments, at 1 week and/or at three months, due to five-daily bilateral
tDCS sessions, either administered alone or in association with
CIMT, beyond the ones achieved by the physical therapy alone or
through the spontaneous recovery.
However, it might be the case that the clinical instruments, or
the limited follow-up, are not sensitive enough to index potential
clinical changes. The idea for this study was based on two hy-
potheses: 1) tDCS, as a plasticity-enhancing intervention, would
facilitate motor-relearning in acute stroke patients enhancing mo-
tor recovery; 2) accordingly to the inter-hemispheric competition
model, bilateral stimulation with anodal tDCS over the AH and
cathodal tDCS over the UH could promote the balance of excitability
between the two hemispheres, with positive effects on functional
recovery [8].
In order to investigate deeper these hypotheses, in experiment
2, we added to the evaluation of the clinical outcome the assess-
ment of the asymmetry of excitability and of the level of plasticity
before and after iTBS, carried on at different time points after
stroke. The results showed that tDCS has an effect on cortical
excitability balancing: the Real_tDCS group undergoes a clear
modulation of AHeUH balance of excitability, to such an extent
that, at three months, no differences between the UH and AH
excitability (Fig. 2A) were found. This aspect is further confirmed by
the study of the LI changes along time: considering as reference
point both t0 (baseline) and t1 (1 week), at t2 (3 months) the
Real_tDCS group shows a reduction of AH-UH imbalance signifi-
cantly different from the Sham_tDCS group (Fig. 3).
As regard the interaction of Real_tDCS with the TBS-promoted
plasticity, we report an enhancement of the AH LTP-like and UH
LTD-like activity and, considering the LI post-iTBS, a significant
reduction of the imbalance (Table 4).
The decrease of the inter-hemispheric imbalance due to the
combination of CIMT with real tDCS was more evident at 1 week as
indexed by the propensity to undergo LTP-like plasticity and at the
3-month for the changes in excitability. Remarkably, this difference
in the time-course of the effects is compatible with the earlier in-
duction of a tDCS-dependent transient modulation of plasticity that
need months to produce consolidated changes and thus to become
evident on a more direct measurable functional index of the motor
corticospinal activity (MEP amplitude).
In summary, although we did not find additional clinical
improvement associated with tDCS, we did find consistent changes
Figure 2. Effect of tDCS on cortical excitability and inter-hemispheric balance. A: Cortical excitability (MEP amplitude mean # SEM) by Group (left panel: Real_tDCS vs right panel:
Sham tDCS) and Hemispheres (orange: Affected hemisphere vs green: Unaffected hemispheres). B: Normalized difference of Laterality Index (LI) (mean # SER) across multiple time
points (t1 " t0 ¼ LI at 1 week e LI baseline; t2 " t0 ¼ LI at 3 months e LI baseline; t2 " t1 ¼ LI at 3 months e LI at 1 week) for the two groups (Sham_tDCS e blue and Real_tDCS e
red). In detail, LI differences are normalized for the LI of second term of the difference (t1 " t0_norm, t2 " t1_norm and t2 " t0_norm): for instance, t1 " t0_norm corresponds to
(LIt1 " LIt0)/LIt0. All MEP amplitudes are measured pre-iTBS.
Table 4
Mean, median and SER of Laterality Index for Real_tDCS and Sham_tDCS groups at multiple time points and normalized differences between time points.
Time Real_tDCS Sham_tDCS
PRE_iTBS POST_iTBS PRE_iTBS POST_iTBS
Mean Median SEM Mean Median SEM Mean Median SEM Mean Median SEM
t0 0.287 0.146 0.122 0.086 0.126 0.042 0.251 0.105 0.126 0.077 0.092 0.030
t1 0.278 0.137 0.122 0.169 0.092 0.110 0.279 0.126 0.123 0.085 0.077 0.039
t2 "0.001 0.006 0.0254 "0.001 0.004 0.018 0.041 0.045 0.017 0.038 0.039 0.017
t1 " t0_norm 0.415 0.143 0.285 "0.180 "0.168 0.352 1.740 0.646 0.930 "0.691 "0.072 0.858
t2 " t0_norm "1.781 "0.992 0.806 "1.052 "0.960 0.318 0.895 "0.270 0.806 1.182 "0.556 2.211
t2 " t1_norm "1.440 "0.992 0.476 "1.052 "1.000 0.249 "0.461 "0.497 0.173 2.606 "0.474 3.241





in neurophysiological parameters; thus, it is worth assessing which
factorsmay be responsible for the dissociation between the positive
neurophysiological results and clinical improvement.
In chronic stroke patients, several studies reported that five to
ten days of bihemispheric tDCS in combination with motor reha-
bilitation (i.e. CIMT) are able to achieve significant clinical gain
[20,31] and in parallel, as in the present study, a reduction of the
inter-hemispheric inhibition from the UH to the AH [20]. Moreover,
in the same paradigm, Lefebvre et al., found in the real tDCS group
not only better learning performance, but also higher retention
abilities including transferring learned skill into new, previously
untrained, tasks [32]. Conversely, and in linewith the present study,
Rossi and co-workers, that enrolled acute stroke patients, showed
that five-daily sessions of anodal tDCS applied to the motor cortex
of the AH appear to be safe, but do not improve clinical outcomes
[33]. It looks like that something differentiates acute and chronic
stroke regarding the ability to respond with improved clinical
outcome to tDCS. It could be argued that, in acute stroke, the level of
plasticity is significantly dysfunctional or it already reaches a ceiling
effect that does not allow five days of tDCS to produce additional
evident clinical benefits, thus longer treatments may be needed.
Accordingly, our data showed a congruent positive trend, although
not-significant, for all the clinical scores at 3 month follow-up and
Reis et al., showed, in healthy, that the only advantage in motor
learning given by tDCS added to motor training was detectable not
before than 3-month after the intervention [34].
Moreover, the visual inspection of the pattern of changes of
excitability from1week to threemonths (Fig. 2A) reveals that the real
tDCS contribution to re-establishing the balance is mostly due to an
inhibitionofUH. It canbespeculated that, in the acutephaseof stroke,
the AH may be not able to respond properly to neuromodulation,
either because of excessive damage or alternatively because of satu-
ration of plasticity induced by the damage itself and the spontaneous
recovery. Along this line, in chronic stroke patients, given that the
recovery of paretic hand motor function is mostly associated with
plasticity of the AH; this may account for the lack of clinical im-
provements in this study. Indeed,whencathodal tDCSofUH, together
with motor training, was associated not only with an inhibition of
the UH, but also with disinhibition of the AH; an improvement in
the ability to retain new motor skills was observed. In addition,
this clinical improvement was correlated with changes of AH [35].
The rationale employed for tDCS setting (cathode over AH and
anode over UH) is based on the inter-hemispheric competition
model [36], however, it is possible that in the acute phase, the
enhanced excitability of UH can be alternatively considered as
compensatory (vicariation model [29]) and thus its inhibition may
be detrimental [37]. Although this model is based on TMS-indexed
excitability changes, the correlation between excitability changes
and behavior may not be true and in fact may change according to
the phase of stroke. Thus results should be interpreted carefully
given this possibility.
A further factor that may be associated with the absence of
clinical improvements is the correct selection of the tDCS param-
eters of stimulation. Indeed, tDCS is commonly considered excit-
atory or inhibitory depending only on the polarity of the electrode
placed over the target area. However, for instance, the duration of
stimulation, and the interval between following sessions, have been
showed to be key factors in determining the direction [38] and the
magnitude of the after-effect [39,40].
Conclusions
This study shows two important novel findings: (i) the addition
of bilateral tDCS to the CIMT significantly reduces inter-hemispheric
imbalance between AH and UH as indexed by TMS induced
neurophysiologic outcomes and this effect is maximal at three-
month follow-up; (ii) tDCS does not lead to additional clinical
benefits in acute stroke despite the positive neurophysiologic
findings. However, inter-hemispheric imbalance is widely consid-
ered as an important predictor of poor rehabilitation outcomes at
the chronic phases of stroke. Then, it may be argued that the
neurophysiologic findings of this study would have a higher impact
on the clinical outcome evaluated in the chronic, rather than the
acute, phases of stroke. Future studies aiming to respond to ques-
tions not answered by the present study are needed, in order to
determine, for instance, the relative contribution of GABA and
glutamate in the described changes of excitability.
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a  b  s  t  r a  c  t
Non-invasive  brain  stimulation  is  presently  being  tested  as  a potential  therapeutic  intervention  for  stroke
rehabilitation.  Following  a model  of competitive  interactions  between  the  hemispheres,  these  interven-
tions  aim  to  increase  the  plasticity  of  stroke  hemisphere  by  applying  either  excitatory  protocols  to the
damaged  hemisphere  or  inhibitory  protocols  to  the non-stroke  hemisphere.  Here  we  test  the  safety  and
feasibility  of  using  an  inhibitory  protocol  on  the  stroke  hemisphere  to  improve  the response  to  conven-
tional  therapy  via  a homeostatic  increase  in learning  capacity.  Twelve  chronic  stroke  patients  received
TBS  to stroke  hemisphere  (6  patients  inhibitory  TBS  and 6  sham  TBS)  followed  by  physical  therapy  daily
for  10  working  days.  Patients  and  therapists  were  blinded  to the  type  of TBS.  Action  Research  Arm  Test
(ARAT),  Nine-Hole  Pegboard  Test  (NHPT)  and  Jebsen–Taylor  Test  (JTT)  were  the  primary  outcome  meas-
ures, grip  and  pinch-grip  dynamometry  were  the  secondary  outcome  measures.  All  patients  improved
ARAT  and  JTT  scores  for up  to 3 months  post-treatment.  ARAT  scores  improved  significantly  in  both  real
and  sham  groups,  but only  patients  receiving  real  TBS significantly  improved  on  the  JTT: 3 months  post-
treatment  mean  execution  time  was  reduced  compared  to  baseline  by 141  s  for real  group  and  by  65  s
for  the sham  group.  This  small  exploratory  study  suggests  that  ipsilesional  inhibitory  TBS  is safe  and  that
it has  the potential  to be  used  in  a larger  trial  to enhance  the  gain  from  a late rehabilitation  program  in
chronic  stroke  patients.
© 2013 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Non-invasive human brain stimulation in the form of repet-
itive transcranial magnetic stimulation (rTMS) or transcranial
direct current stimulation (tDCS) can induce long-lasting changes
in the excitability of central motor circuits via long-term
potentiation/depression (LTP/LTD)-like phenomena that share
∗ Corresponding author at: Institute of Neurology, Campus Biomedico University,
Via Alvaro del Portillo 200, 00128 Rome, Italy. Tel.: +39 06225411320;
fax: +39 06225411936.
E-mail address: v.dilazzaro@unicampus.it (V. Di Lazzaro).
major properties of LTP/LTD described at cellular level [18]. Sev-
eral recent studies tested whether induction of LTP-like effects
in the stroke hemisphere can enhance the effects of motor reha-
bilitation after stroke [10,16]. The hypothesis is that stimulation
facilitates the stroke hemisphere and initiates changes in synap-
tic plasticity that improve therapy by enhancing learning-related
changes in synaptic connections that are required for reacquisition
of skills [17]. Conversely, inhibitory stimulation of the non-stroke
hemisphere might reduce its excitability and reduce transcallosal
inhibition of stroke hemisphere, with the same consequences for
learning. Several clinical studies reported some positive effects
from repeated sessions of brain stimulation [1], however, the effects
were limited and variable.
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Recent work has, however, suggested that rTMS could improve
learning via a different mechanism that involves the phenomenon
of “homeostatic” plasticity. This postulates that the ease of pro-
ducing synaptic LTP/LTD depends on the prior history of neural
activity. The greater the activity the more difficult it is to induce
LTP; whereas LTD is more difficult to induce with a history of low
activity. Homeostatic-like interactions have been reported in the
human brain using a variety of brain stimulation protocols [12]. For
example, a protocol capable of inducing LTD-like effects strongly
facilitates motor learning while protocols inducing LTP-like effects
have a less pronounced and short-lived facilitatory effect on learn-
ing [12]. In the context of stroke this would predict that, contrary
to present practice which uses excitatory protocols, an inhibitory
rTMS protocol that induces LTD-like effects on the stroke hemi-
sphere would lead to better relearning in stroke patients through
mechanisms of homeostatic metaplasticity [12].
We  designed a proof-of-principle double blinded semi-
randomised sham-controlled trial to assess the safety and potential
efficacy of this approach by measuring whether clinically impor-
tant long-lasting differences can be achieved by adding continuous
theta burst stimulation (cTBS) of the lesioned hemisphere to a
standardized physiotherapy protocol for the upper limb in chronic
stroke. CTBS is a robust form of inhibitory rTMS; its after-effects,
thought to be due to LTD-like changes [8], can last up to 1 h, an
excellent time window for a therapy session. We  hypothesized that
immediate and long-term outcomes of the active treatment would
be significantly better than sham treatment.
2. Subjects and methods
2.1. Subjects
12 chronic stroke patients gave their written informed consent
for the study which was performed according to the Declaration
of Helsinki and approved by the local ethics committee. Inclusion
criteria were: (a) first-ever ischemic stroke at least 1 year earlier;
(b) moderate residual hand function, defined as grasp strength ≥1%
of the unaffected hand, preserved extension at the wrist (≥20◦), and
baseline score in Nine Hole Pegboard Test (NHPT) ≤70% of the unaf-
fected hand; (c) ability to give informed consent and comprehend
instructions. Exclusion criteria were: (a) significant spasticity (Ash-
worth score >2); (b) patients not able to perform dynamometry;
(c) concomitant neurological conditions, including any history of
epilepsy and significant comorbidities; (d) cognitive impairment
or any substantial decrease in alertness, language reception, or
attention that might interfere with understanding instructions for
motor testing; (e) apraxia; (f) excessive pain in any joint of the
paretic extremity; (g) contraindications to TMS  such as metal head
implants; (h) advanced liver, kidney, cardiac or pulmonary disease;
(i) history of significant alcohol or drug abuse; (l) depression or use
of neuropsychotropic drugs such as antidepressants or benzodi-
azepines. The National Institute of Health Stroke Scale (NIHSS) and
the Barthel Index (BI) were used to evaluate neurological impair-
ment and disability at the enrolment.
2.2. Primary outcome measures
Since this was an exploratory trial in which we aimed to evalu-
ate changes in global hand function, we chose 3 primary outcome
measures that evaluate different aspects of that. These were Action
Research Arm Test (ARAT; score 0–57), Jebsen-Taylor Test (JTT) and
Nine Hole Pegboard Test (NHPT).
(1) ARAT is a broad measure of upper extremity function in patients
with focal disability [7].
(2) Jebsen–Taylor Test (JTT) has been shown to be valid and reliable
in the normal population [11] and in chronic stroke patients
[5,9]. The modified version used here has 6 subsets. Items were
tested 5 times at each assessment. The time in seconds to com-
plete each subset was recorded: the maximal amount of time
allotted for each item was 120 s so that 120 s were assigned to
the tasks that could not be concluded [4]. The hands were tested
alternately. Since performance stabilizes after 2–3 trials, only
the last two  trials were averaged and used for analysis. How-
ever, to better characterize performance in patients who were
not able to perform any of the JTT tasks at baseline, we used the
method of calculation performed in one of our previous stud-
ies about hand function in chronic stroke patients [14]. Thus,
scores were normalized to the performance of unaffected hand
and computed as follows: cannot do or <0.05 = 1, 0.05–0.09 = 2,
0.1–0.14 = 3, and so on; thus, the range was 1–20, each point
reflecting an improvement of 5% of the maximum score that is,
the score of the unaffected hand. The items were then summed
to produce a JTT total score (range 6–120, 11.4 points reflecting
10% improvement) [14].
(3) NHPT is a test sensitive to changes in finger dexterity [6]. Each
hand was tested alternately for 3 times, starting from the paretic
one. Sixty seconds were allowed for each single attempt: if not
completed, the number of pegs placed in 60 s was recorded.
Final scores were computed as the ratio pegs/s placed by the
paretic hand, averaged over 3 trials and normalized to the aver-
age score of the unaffected hand (range 0–1; 0, cannot do).
2.3. Secondary outcome measures
Grasp and pinch grip dynamometry were performed using a dig-
ital dynamometer (Biometrics Ltd, Newport, UK). Each patient was
instructed to perform 3 attempts at grip and pinch, alternating the
hands. Maximal grip strength, when normalized to the unaffected
hand, is highly reproducible in chronic stroke patients [2].
2.4. Motor cortex excitability
We evaluated changes in motor cortex excitability in a subgroup
of patients [4 in the real group (mean age: 59.5 ± 11.7 (SD) years)
and 4 in the sham group (age: 56.7 ± 16.1; p = 0.5)] of both affected
(AH) and unaffected (UH) hemisphere at baseline, T1 and T2.
AMT  was  evaluated for all the patients of the real group at each
time point to set the intensity for cTBS.
Magnetic stimulation was performed with a high-power
Magstim 200 (MagstimCo., Whitland, Dyfed). A figure-of-eight coil
with external loop diameters of 9 cm was held over the motor cor-
tex at the optimum scalp position to elicit MEPs in the contralateral
first dorsal interosseous muscle (FDI). The induced current flowed
in a postero-anterior direction.
For both AH and UH, we  evaluated active (AMT) and resting
(RMT) motor threshold and amplitude of motor evoked poten-
tials (MEPs). MEPs were band pass filtered (bandwidth 3 Hz–3 kHz)
(Digitimer D360 amplifiers) and each single trial was  recorded
on computer for later analysis using a CED 1401 A/D converter
(Cambridge Electronic Design, Cambridge, UK) and associated soft-
ware. The responses to 20 stimuli obtained at rest at an intensity of
120% RMT  were averaged.
2.5. Interventions
Real or sham brain stimulation, followed by physical therapy
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2.5.1. Transcranial brain stimulation
rTMS was applied over the hand motor area of the AH using
a MagPro stimulator (Medtronic A/S, Denmark) and a figure-of-
eight shaped coil (MCF-B65) with the handle pointed posteriorly
and approximately perpendicular to the central sulcus.
Active rTMS used continuous Theta Burst Stimulation (cTBS)
in which 3 pulses are given at 50 Hz, repeated every 200 ms  for
a total of 600 pulses. Stimulation intensity was 80% active motor
threshold (AMT), defined as the minimum single pulse intensity
required to produce a motor evoked potential greater than 200 !V
on more than five out of ten trials from the contracted contralateral
first dorsal interosseous muscle. CTBS at this intensity suppresses
cortical excitability reaching a maximum effect at about 5–10 min
after the end of the stimulation [9]. Affected hemisphere AMT  was
determined at each session to adjust cTBS intensity.
Sham rTMS was performed using the same stimulator connected
to the placebo coil (MCF-P-B65) which has no stimulating effect but
produces similar auditory and tactile sensations as the active coil.
The site of stimulation and the number of stimuli were identical to
those used for the active rTMS protocol. Sham TBS intensity was
arbitrarily set at 50% of MSO.
2.5.2. Physical therapy
Physical therapy included strength training for the wrist, fin-
gers and thumb and grasp and repetitive task practice; the latter
aimed mainly at hand function, including, however, proximal ele-
ments through functional reach to different areas within the work
space. It was designed to ensure the same intensity of intervention
independent of baseline functional ability, as described in detail in
an earlier publication [15]. Each session lasted approximately 1 h.
Therapy was given by a single certified physiotherapist.
3. Experimental design
All the patients received physical therapy. They were random-
ized to active (n = 6, mean age: 59.5; SD: 12.4; range: 46–75) or
sham cTBS (n = 6; mean age: 57.5; SD: 12.6; range: 39–76) through
a randomization stratification approach. We  stratified the groups
by using NIHSS, BI and ARAT at baseline to ensure that both groups
had a similar distribution regarding degree of impairment.
Researcher randomizing patients and researchers delivering
cTBS were not involved in outcome assessments and data analy-
sis; the physiotherapist, patients and researchers involved in data
analysis were blind to the type of cTBS delivered (i.e. sham or real),
in order to obtain a double-blinded sham-controlled study design.
ARAT, NHPT and JTT were evaluated at baseline (T0) and 4 days
(T1), 1 month (T2) and 3 months (T3) after the end of the treatment;
cortical excitability, grasp and pinch strength were evaluated at T0,
T1 and T2 (Fig. 1).
Fig. 1. Study design. Timing of clinical evaluations with respect to the end of
treatment. Treatment (real/sham cTBS + physical therapy) was  delivered for 10
consecutive working days. Baseline evaluation was  performed in the first day of
treatment ARAT: Action Research Arm Test; JTT: Jebsen–Taylor Test; NHPT: Nine
Hole Pegboard Test; TMS: transcranial magnetic stimulation (motor cortex excitabil-
ity  study); cTBS: continuous Theta Burst Stimulation.
Table 1
Demographic and clinical characteristics of the patients at baseline.
cTBS (N = 6) Sham (N = 6) p
Age (years)a 59.5 ± 12.4 57.5 ± 12.3 0.78
Sex  (M/F) 3/3 4/2 0.77c
MSS  (months)a 34.8 ± 17.5 30 ± 27.6 0.7d
Lesion location
Subcortical 0/6 1/6
Cortical involvemente 6/6 5/6
Lesion side (% dominant) 1/6 2/6 0.85c
Barthel indexa 16.5 ± 3.27 18.3 ± 1.3 0.24d
NIHSSa 3.1 ± 1.5 4.0 ± 1.4 0.34b
ARATa 21.8 ± 8.6 23.6 ± 10.2 0.74b
NHPT (ah/hh ratio)a 0.03 ± 0.03 0.02 ± 0.02 0.33b
JTT (normalized scores; ah)a 17.5 ± 8.9 19.0 ± 14.9 0.83b
JTT (s; ah)a 415 ± 184 416 ± 247 0.99b
Grasp (ah/hh ratio)a 0.5 ± 0.1 0.33 ± 0.16 0.06b
Pinch grip (ah/hh ratio)a 0.3 ± 0.15 0.45 ± 0.31 0.32b




e Sparing the primary motor cortex.
MSS: months since stroke; NIHSS: National Institute of Health Stroke Scale; ARAT:
Action Research Arm Test; NHPT: Nine-Hole Pegboard Test; JTT: Jebsen–Taylor Test;
ah: affected hand; hh: healthy hand.
4. Statistics
We  analyzed ARAT, NPHT, JTT time and JTT normalized scores
using separate repeated measures ANOVA with TIME (T0, T1, T2
and T3) as within-subject factor and GROUP (real vs sham cTBS) as
between-subject factor; grasp and pinch strength were analyzed in
the same way but with only 3 time points (T0, T1 and T2). When
significant main effects or interactions were found, post hoc paired
two tailed t-tests were performed. The level of significance was
set at P < 0.05: both for primary and secondary outcome measures
we performed correction for multiple comparisons by Bonferroni
method, so that p value was  set at 0.017.
Before entering the data in ANOVA, we performed
Kolmogorov–Smirnov (KS) test to check for normal distribution.
5. Results
There were no adverse events. Groups were balanced at baseline
for age, time from the acute event, NIHSS, BI, lesion side, M/F  ratio
and residual hand function as evaluated by ARAT and JTT baseline
scores (Table 1).
KS test revealed that all the data were normally distributed.
5.1. Primary outcome measures
5.1.1. ARAT
Repeated measures ANOVA showed a significant effect of TIME
(F3,10 = 29.4; p < 0.001), but no significant TIME × GROUP inter-
action (F3,30 = 0.16; p = 0.9). Thus, physical therapy was effective
regardless the rTMS intervention. Nevertheless, we explored the
effect of TIME in more detail by a within-group comparison exam-
ining changes from baseline in each group (real- and sham-cTBS)
with paired t-tests. Both real- and sham-cTBS groups improved sig-
nificantly at T1, T2 and T3 (Fig. 2). Patients undergoing real cTBS
increased mean ARAT score above baseline by about 30% at T1 and
by about 36% at T2, T3. The sham group increased about 27% at T1,
about 30% at T2 and about 34% at T3.
5.1.2. JTT
Repeated measures ANOVA for JTT execution time showed a
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Fig. 2. Mean scores in upper limb function tests before and after intervention. Error bars represent standard deviations; *p < 0.017, comparisons were done always toward
baseline in the same group (i.e. T1 vs baseline, T2 vs baseline, T3 vs baseline). ah: affected hand; hh: healthy hand.
TIME × GROUP interaction (F3,30 = 3.173; p = 0.03). This simple mea-
sure of the time taken to perform the JTT might not provide a good
description of the data if patients cannot perform any of the tasks
at baseline, but then succeed after treatment. To account for this,
we also used a normalized score in which we express the perfor-
mance of the affected side as a percentile of the performance of the
unaffected side (see Ref. [16] for further details). A repeated meas-
ures ANOVA on these normalized scores showed a significant effect
of TIME (F3,10 = 8.84; p = 0.0002) but no significant TIME × GROUP
interaction (F3,30 = 1.9; p = 0.1). However, a within-group compar-
ison (both for performance time and normalized scores) revealed
that only the patients who underwent real cTBS improved at T1, T2
and T3 (p = 0.01, p = 0.01 and p = 0.015 respectively for performance
time; p = 0.01, p = 0.02 and p = 0.03 respectively for normalized
scores), whereas no significant effect of TIME was  found in the
sham group (Fig. 2). In patients undergoing real cTBS, mean JTT
execution time was reduced compared to baseline by 116 s at T1,
147 s at T2 and 141 s at T3 whereas for the sham group the mean
reduction in performance time was 51, 63 and 65 s at the same
time points; furthermore normalized scores increased compared
to baseline by about 55% at T1, 70% at T2 and 60% at T3, whereas
for the sham group the mean increase was between 15% and 22% at
the same time points. Between groups post hoc analysis revealed
no significant differences at each time point for both measuring
methods.
5.1.3. NHPT
There was a significant effect of TIME (F3,10 = 5.42; p = 0.004)
but no significant TIME × GROUP interaction (F3,30 = 0.108; p = 0.9).
A within-group comparison revealed that both the real- and the
sham-cTBS groups had a similar but non-significant trend toward
improvement at the three time points post-intervention (T1: real
p = 0.08, sham p = 0.16; T2: real p = 0.08, sham p = 0.27; T3 real
p = 0.10, sham p = 0.10) (Fig. 2).
5.2. Secondary outcome measures
5.2.1. Grasp and pinch grip dynamometry
ANOVA revealed no significant effect of TIME (grasp F2,10 = 1.3,
p = 0.29; pinch F2,10 = 1.03, p = 0.37) nor significant TIME × GROUP
interaction (grasp F2,20 = 2.3, p = 0.12; pinch F2,20 = 1.1, p = 0.34)
(Fig. 2).
5.2.2. Motor cortex excitability
At baseline paired t-test revealed a significant difference in MEP
amplitude between UH and AH in both subgroups [(UH vs AH);
real group: 606 ± 240 !V vs 160 ± 177 !V (p = 0.01): sham group:
421 ± 205 !V vs 90 ± 75 !V (p = 0.01)]. No significant difference at
baseline was  disclosed in motor thresholds and MEP  amplitude for
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ANOVA revealed no significant effect of TIME nor significant
TIME × GROUP interaction for both motor threshold and for MEP
amplitude. No significant change in AMT  was seen at different time
points for both studied groups.
6. Discussion
This exploratory trial tested the idea that application of an
inhibitory form of rTMS to the stroke hemisphere can improve the
response to physical therapy via a homeostatic action on synaptic
plasticity and hence on learning. Importantly, we found no delete-
rious effects of cTBS on recovery, as might have been expected if it
had had the opposite effect to the presently used non-homeostatic
protocols, since all patients showed some improvement in func-
tion. Patients in both real and sham groups achieved sustainable
improvements in the ARAT, NHPT and JTT, illustrating the success of
the therapy. However, only patients who underwent real cTBS had
a significant improvement in JTT while both the real- and the sham-
cTBS groups improved in the ARAT and NHPT. We  observed a mean
reduction in JTT performance time, when compared to baseline val-
ues, by 116 s at T1, 147 s at T2 and 141 s at T3 for the real group
whereas for the sham group the mean reduction in performance
time was 51, 63 and 65 s at the same time points. Furthermore,
this difference between real and sham group was confirmed by
a within-group comparison examining changes of JTT normalized
scores from baseline in each group (real- and sham-cTBS). Although
all patients improved on functional measures of motor ability, there
was no change in handgrip strength. Nevertheless, since the data
were similar in real and sham groups, it cannot be viewed as an
adverse effect from pre-treatment with real-cTBS.
We hypothesize that cTBS, by reducing excitability and induc-
ing LTD-like changes, might enhance and/or accelerate the training
process and the effects of rehabilitation [13]. However, there is
another possible explanation for the results. Bradnam et al. [3] sug-
gested that in some patients, recovery of function is mediated by
increased ipsilateral control from the non-stroke hemisphere. If this
were the case, then inhibitory cTBS to the stroke hemisphere may
remove interfering activity and allow the non-stroke hemisphere to
improve its response to rehabilitation. Although possible, we think
this unlikely since inhibition from the stroke hemisphere onto the
non-stroke hemisphere should be much reduced, such that removal
would have little effect on function. This point can be investigated
by evaluating the excitability of the healthy and stroke hemisphere
before and after treatment. In present study we showed no signifi-
cant change in cortical excitability after the treatment both for the
AH and UH. However, further studies evaluating also the changes
in ipsilateral MEPs after stimulation of the healthy hemisphere are
needed to better understand the contribution of ipsilateral path-
ways in the recovery.
There were no between-group differences in outcome measures
other than JTT, perhaps because of the relatively small number of
patients. Nevertheless it could be also associated with the speci-
ficity and sensitivity of the individual measures. For example the
JTT, unlike other measures, improves with practice particularly in
naive individuals [5,9]. This is why 5 trials were allowed at each
assessment and only the last two ones were used for analysis. In our
previous study, a clear learning curve was seen in the pre-treatment
assessments but not in the post-treatment ones; in other words
there was no further learning with practice after the treatment
period (Talelli, unpublished data). If the intervention in this study
creates an environment that facilitates practice-induced learning it
is possible that patients continued improving in the JTT tasks during
the 5 trials in the post-treatment assessments and thus achieved
a higher plateau. The lack of significant variations in the other
clinical scales could be due to an occlusion effect between TMS
and rehabilitation for the functions explored by these scales, that
is, the improvement produced by rehabilitation cannot be further
enhanced by adding cTBS.
Previous studies combining standard rehabilitation with rTMS
protocols that enhance ipsilesional excitability or suppress
contralesional excitability were based on a non-homeostatic inter-
action of brain stimulation and motor training and their results
have been conflicting and variable. Even though our results should
be considered with caution, due to the limited number of patients
included, cTBS used in a homeostatic protocol may  prove to be
another potential therapeutic intervention after stroke. Future
studies could define the optimal number of cTBS sessions and the
most appropriate time of intervention.
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Paper 1: Differential Effects of HRAS Mutation on LTP-Like 
Activity Induced by Different Protocols of Repetitive 
Transcranial Magnetic Stimulation 
	
 
In Costello Syndrome (CS) patients mean baseline-normalized 
MEP am- plitude was increased by about 250% immediately after PAS 
and by approximately 320% when evaluated at 30 minutes after the end 
of PAS, whereas after iTBS we observed no significant change of MEP 
amplitude at the two time-points. In healthy subjects we observed an 
increase in baseline-normalized MEP amplitude by about 73% at T1 and 
by about 39% at T2 after PAS and an increase by about 51% at T1 and 
by about 40% at T2 after iTBS: post hoc unpaired t-test for comparison 
of the effects of the two stimulation protocols in healthy group did not 
reveal any significance, that means that iTBS and PAS produce the 
same facilitatory effect in baseline-normalized MEP amplitude of 
controls.  
When CS were compared to controls, iTBS induced a significant 
increase in baseline-normalized MEP amplitude in controls, but not in 
CS patients and conversely we confirmed that PAS induced a 
significantly more pronounced increase of MEP amplitude in CS when 
compared to control group. 
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Paper 2: The Level of Cortical Afferent Inhibition in Acute 




AH-SAI and AH-MEP amplitude were lower than corresponding 
UH and control values. No evidence of association between 
electrophysiological parameters and stroke severity in the acute phase 
was found. Looking at correlations with clinical status at 6 months, the 
only significant associations were found with AH-SAI. 
When the effect of AH-SAI on mRS was adjusted for the 
confounding effect of baseline clinical status (National Institutes of 
Health Stroke Scale at T0), the nonparametic partial correlation 
remained significant (rho 0.66; P 0.016), suggesting its relevance even 
equalizing for baseline clinical status. 
There was no correlation between AH-SAI and either slope of the 
input–output curve or site of the lesion. Also, there was no correlation 
between site of the lesion and recovery at 6 months. 
Involvement of cholinergic pathways was limited and there was no 
correlation between AH-SAI and either percentage of lesional voxels of 
medial pathway, lateral cholinergic pathways and lateral perforant 






Paper 3: Immediate and late modulation of interhemispheric 
imbalance with bilateral transcranial direct current stimulation 




Experiment 1. For each clinical measure (NIHSS, mRS, ARAT, 
NHPT, NIHSS, MAL (AOU), MAL (QOM)) we computed a repeated 
measure ANOVA with Time as within subject factor (2 levels: baseline, 1 
week) and tDCS (two levels: real and sham) as between subject factors. 
tDCS had no effect on clinical outcome (tDCS and the tDCS by Time 
interaction: P > 0.200 consistently). We confirmed the expected and 
well-known time-related clinical improvement (factor Time P < 0.001 for 
all the measures considered). 
Experiment 2. The repeated measure ANOVA with Time as within 
subject factor (3 levels: base, 1 week, 3 months) and tDCS (2 levels: real 
and sham) as between subject factor showed the absence of tDCS 
effect on clinical outcome (factor tDCS and tDCS by Time interaction: P 
> 0.050 consistently). 
 
Cortical excitability  
Experiment 2. The aim of the analysis was to check whether there 
was a change of brain excitability across hemispheres, time and groups. 
The two groups (real tDCS vs. sham tDCS) had no different 
excitability at baseline (t0), as demonstrated by the lack of tDCS factor 
effect (Wald chi-square 1⁄4 0.352, df 1⁄4 1, P 1⁄4 0.553) and of 
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Hemisphere by tDCS interaction (Wald chi-square 1⁄4 066, df 1⁄4 1, P 1⁄4 
0.797). The inter-hemispheric excitability imbalance, well-known in acute 
stroke, was confirmed in both groups by the presence of a main effect of 
Hemisphere (Wald chi-square 1⁄4 15.334, df 1⁄4 1, P < 0.001). 
The further step was to compare the excitability of the two groups 
(real tDCS and Sham tDCS) along the time-course of the investigation 
computing a GEE model with Patient as “Subject” (or cluster) variable, 
MEP values as dependent variable and Hemisphere (AH and UH), Time 
(t0, t1, t2) and tDCS (Real and Sham) as predictors. The presence of a 
significant triple interaction Time by Hemisphere by tDCS (Wald chi-
square 1⁄4 31.652, df 1⁄4 7, P < 0.001) showed that the inter-hemispheric 
balance of excitability is differently modulated along time accordingly 
with tDCS exposure (real tDCS and Sham tDCS). 
In the context of the effect of tDCS on the inter-hemispheric 
balance, the Real_tDCS group, compared to the Sham_tDCS group, 
showed a reduction of LI when considering both t2   t1_norm (P 1⁄4 
0.007) and t2   t0_norm (P 1⁄4 0.015).  
In summary, the main effect of tDCS was the reduction of inter- 
hemispheric imbalance at 3 months of follow-up. 
 
LTP/LTD-like changes promoted by iTBS  
Experiment 2. We wanted to evaluate whether the addition of 
tDCS to a CIMT protocol can change the amount of LTP of the AH and 
of LTD of UH promoted by iTBS applied over the AH. We computed a 
GEE model with Patient as “Subject” (or cluster) variable, MEP values as 
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dependent variable and Hemisphere (AH and UH), tDCS (Real and 
Sham), Time (t0, t1, t2) and TBS (Pre-TBS and Post-TBS) as predictors. 
The presence of a significant Hemisphere by Time by TBS by 
tDCS interaction (Wald chi-square 1⁄4 41.472, df 1⁄4 14, P < 0.001) 
suggests that the effect of TBS on each hemisphere differently changes 
along time in the two groups. 
Once the GEE model with Hemisphere (AH and UH), Time (t0, t1, 
t2) and TBS (Pre-TBS and Post-TBS) as predictors was applied 
separately for each group, we found a significant Hemisphere by Time 
by TBS interaction only for the Real_tDCS group (Real_tDCS: Wald chi-
square 1⁄4 28.870, df 1⁄4 7, P < 0.0001; Sham_tDCS: Wald chi- square 
1⁄4 6.350, df 1⁄4 7, P 1⁄4 0.499). Therefore, in other words, the “Real 
tDCS” supports a different modulation of TBS effects across 
Hemispheres and Time. The visual inspection of the curves suggests 
that at t1 iTBS produced both greater increase of AH excitability and 
decrease of UH excitability in patients exposed to Real_tDCS. 
Finally, the post-iTBS study of LI suggests that real tDCS de- 
creases inter-hemispheric imbalances compared to Sham_tDCS. In 
other words, tDCS improves baseline inter-hemispheric balance and 








Paper 4: Inhibitory theta burst stimulation of affected 




There were no adverse events. Age, time from the acute event, 
NIHSS, BI, lesion side, M/F ratio and residual hand function as 




Repeated measures ANOVA showed a significant effect of TIME, 
but no significant TIME×GROUP interaction. Thus, physical therapy was 
effective regardless the rTMS intervention. Nevertheless, we explored 
the effect of TIME in more details by a within-group comparison 
examining changes from baseline in each group (real- and sham-cTBS) 
with paired t-tests. Both real- and sham-cTBS groups improved 
significantly at T1, T2 and T3. Patients undergoing real cTBS increased 
mean ARAT score above baseline by about 30% at T1 and by about 
36% at T2, T3. The sham group increased about 27% at T1, about 30% 
at T2 and about 34% at T3. 
 
JTT 
Repeated measures ANOVA for JTT execution time showed a 
significant effect of TIME and a significant TIME × GROUP interaction. 
This simple measure of the time taken to perform the JTT might not 
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provide a good description of the data if patients cannot perform any of 
the tasks at baseline, but then succeed after treatment. To account for 
this, we also used a normalized score in which we express the 
performance of the affected side as a percentile of the performance of 
the unaffected side. A repeated measures ANOVA on these normalized 
scores showed a significant effect of TIME but no significant TIME × 
GROUP interaction. However, a within-group comparison (both for 
performance time and normalized scores) revealed that only the patients 
who underwent real cTBS improved at T1, T2 and T3 (p = 0.01, p = 0.01 
and p = 0.015 respectively for performance time; p=0.01, p=0.02 and 
p=0.03 respectively for normalized scores), whereas no significant effect 
of TIME was found in the sham group. In patients undergoing real cTBS, 
mean JTT execution time was reduced compared to baseline by 116 s at 
T1, 147 s at T2 and 141 s at T3 whereas for the sham group the mean 
reduction in performance time was 51, 63 and 65s at the same time 
points; furthermore normalized scores increased compared to baseline 
by about 55% at T1, 70% at T2 and 60% at T3, whereas for the sham 
group the mean increase was between 15% and 22% at the same time 
points. Between groups post hoc analysis revealed no significant 
differences at each time point for both measuring methods. 
 
Motor cortex excitability 
At baseline paired t-test revealed a significant difference in MEP 
amplitude between UH and AH in both subgroups [(UH vs AH); real 
group: 606 ± 240  V vs 160 ± 177  V (p = 0.01): sham group: 421 ± 205  
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V vs 90 ± 75  V (p = 0.01)]. No significant difference at baseline was 
disclosed in motor thresholds and MEP amplitude for both hemispheres 
between the two studied groups. ANOVA revealed no significant effect of 
TIME nor significant TIME × GROUP interaction for both motor threshold 
and for MEP amplitude. No significant change in AMT was seen at 




By means of this “excursus”, it was demonstrated that: 
1. Neuromodulation techniques, although in healthy subjects could 
lead to similar effects (same direction and similar effect size), 
differ in the underlying mechanisms of action, especially when 
observe them at cellular and intracellular level. It was indirectly 
demonstrated by studying the cohort of CS patients: the presence 
of a single mutation in a ubiquitous intracellular protein cascade 
involved in learning and plasticity influence the after-effects of two 
similar facilitatory rTMS protocols in a differential manner (paper 
1). 
2. RTMS-induced (and for deduction of all kinds of neuromodulation 
protocols) LTP-like after-effects are not always correlated with 
good learning processes and if excessive could be detrimental 
(paper 1) 
3. By studying motor cortex excitability in the acute phases after a 
stroke, it is possibile to better characterize the patients in terms of 
their “natural” tendency to motor recovery (paper 2). 
4.  Increasing the excitability of the AH and reducing the excitability 
of the UH, besides the induced neurophysiological changes, 
doesn’t lead to a clinical improvement in acute stroke patients in 
terms of motor recovery (paper 3). 
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5. Conversely, reducing the excitability of the AH in chronic stroke 
patients induce an amelioration in motor tasks in the paretic hand 
without any side effects (paper 4).    
Hence, it could be firstly concluded that non-invasive brain 
stimulation techniques have a potentially central role in studying stroke 
patients and their propensity to motor recovery. Indeed, TMS permits a 
non-invasive, non-painful, feasible and safe evaluation of motor cortex 
excitability in stroke patients. Furthermore, neuromodulation, in the form 
of rTMS or tDCS, could be a useful and effective add-on treatment in the 
post-stroke phase with the ultimate aim to achieve an improvement of 
the degree of motor recovery.  
If boosting the effects of physical therapy is achieved, it could be 
possible to reduce the social costs of the illness, by reducing the global 
time of rehabilitation (as well as in inpatients or outpatients clinics 
modality) and increase the quality of life after stroke in the survived 
cohort. 
Ras signalling plays a key-role on the structural and functional 
synaptic connectivity within cerebral cortex and is strictly connected to 
synaptic LTP [97], motor learning and memory [98]. It should be noted 
that the differential influence of HRAS mutation on the after-effects of 
two similar (i.e. facilitatory) rTMS techniques suggests that non-invasive 
brain stimulation techniques, as far as inducing in healthy subjects the 
same gross effects, could activate different intracortical pathways 
inducing LTP. Indeed, some differences in the neuromodulatory 
mechanisms of PAS and iTBS were already demonstrated in 
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Parkinson’s Disease (PD) patients in which L-dopa was able to restore 
abnormal plasticity induced by PAS [99-101] but not the abnormal 
response to iTBS [102]. Moreover this hypothesis fits well with the 
experimental evidence that different stimulation protocols could activate 
different pathways inducing LTP and with the evidence of a differential 
activation of different cortical circuits [103] by means of different NIBS 
protocols [104]. If this was the case, this concept could be generalized to 
all the neuromodulation protocols, in the sense that not all the stroke 
patients could benefit from the same protocol, depending on their 
genetic background and specific condition. Furthermore, HRAS mutation 
in CS is associated to a paradoxical increase in LTP associated to 
decreased motor function in animal models: the “in vivo” replication of 
these findings by means of NIBS protocols could suggest that the 
artificial increase in LTP could be detrimental and not beneficial (paper 
1). Furthermore it was also shown that downregulation of Ras-
dependent cascade could enhance motor recovery in experimental 
models of stroke [105]. 
Altogether these considerations suggest that the choice of a NIBS 
protocol as a technique boosting motor recovery after stroke, and, in 
general, as a potential add-on treatment in neurological illnesses, could 
be the first crucial step to achieve more effective results.  
Moreover, we observed a suppression of SAI in acute stroke 
patients and, remarkably, that AH-SAI level was inversely correlated with 
recovery at 6 months. Since SAI is probably mediated by the α5-subunit 
of GABA receptor [106], and since pharmacological antagonization of 
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α5-subunit activity was showh to promote functional recovery after 
stroke [107], we hypothesized that SAI suppression, and its correlation 
with motor improvement, might be related to a reduction of activity 
related to this subunit. These findings are very interesting and could 
suggest a tailored rehabilitation and neuromodulation approach for each 
stroke patients depending on the level of SAI measured in the acute 
phase. In other words, patients with less reduced SAI could benefit of 
larger and “aggressive” rehabilitation scheme while patients with a more 
reduced SAI (theoretically more prone to a good recovery) could benefit 
of more intensive, earlier and shorter rehabilitation schemes. 
Nevertheless, when a contemporary inhibition of the excitability of 
healthy hemisphere and a facilitation of the affected hemisphere were 
induced by means of bilateral tDCS (delivered for 40 minutes daily for 5 
consecutive days) during the acute phase after a stroke (paper 3), a 
significantly reduction of inter-hemispheric imbalance between AH and 
UH was found without any significant change in hand motor function. In 
other words alleviating the inter-hemispheric imbalance didn’t translate 
into a better motor function for the paretic hand. Contemporary we 
demonstrated that NIBS application in acute stroke could be considered 
a safe procedure and that bilateral tDCS was able to increase LTP-like 
effects in AH at 3 months. In line with present results, Rossi and co-
workers showed that five-daily sessions of anodal tDCS applied to the 
motor cortex of the AH in acute stroke patients appear to be safe, but do 
not improve clinical outcomes [108]. Considering the relative small 
cohort of recruited patients in both studies, it could also be conceivable 
Discussion 
	 74	
that clinical negative results were due to the intra-cohort variability 
related to lesion size, affected hemisphere, lesion site (cortical vs 
subcortical) as well as age, risk factors and so on and our study was 
underpowered. However, these data seem to suggest two major 
considerations: 
1. In acute stroke, the level of plasticity could be significantly 
dysfunctional or, if considered compensatory, it already reaches a 
ceiling effect that does not allow five days of tDCS to produce 
additional evident clinical benefits. 
2. Since the neurophysiological rebalancing of inter-hemispheric 
motor cortex excitability didn’t translate in clinical improvement, it 
could be suggested that the competition model is not the 
adequate rationale to follow (at least in the acute phase) for 
promoting motor recovery after a stroke and the application of 
other strategies should be investigated.  
In line with this last consideration, we could hypothesize that the 
increase of UH excitability as well as the reduction of AH excitability 
could be considered a compensatory and not purely detrimental 
phenomenon in both acute and chronic phases after a stroke.  
So, the relative failure of the previous study seems to indicate 
also the relative failure of the inter-hemispheric competition model.  
In this line, we tried another small trial of NIBS application in 
stroke patients (in this case, chronic), in which we applied the 
“alternative” rationale of the compensatory model [88]. 
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Following this last consideration in a different study (paper 4) we 
tried to follow the “compensatory/vicariation” rationale and applied an 
inhibitory rTMS protocol (i.e. cTBS) over AH in a cohort of chronic 
paretic stroke patients. We found no deleterious effects of cTBS both on 
safety matters and on recovery measures (i.e. a worsening in motor 
function), as might have been expected if competition model was 
working: all the patients showed some improvement in motor function of 
the paretic hand. Specifically, all the patients (in both real and sham 
groups) achieved sustainable improvements in the ARAT, NHPT and 
JTT, illustrating the success of the physical therapy. However, only 
patients who underwent real cTBS had a significant improvement in JTT. 
Contemporary no change in bilateral motor cortex excitability were 
observed. Unfortunately we didn’t study the acute neurophysiological 
after-effects of a single session of cTBS on AH, to disclose the presence 
of a different response when compared with healthy subjects and to 
have more mechanistical data. So, we hypothesized that inducing LTD-
like changes in AH might enhance and/or accelerate the learning 
process and the effects of rehabilitation: this mechanism could fall into 
the concept of metaplasticity, the lower the neural excitability the higher 
the probability of consolidated motor learning [24]. However, it could be 
possible that cTBS had induced a reduction of interference from the 
stroke hemisphere towards the healthy hemisphere disinhibiting UH 
ipsilateral corticospinal control over paretic hand, as suggested by 
Bradnam and colleagues [109].  
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Whatever the explanation, with an adequate caution in 
considering these data definitive, this research trajectory seems 
suggesting that the inter-hemispheric competition model (that guided the 
majority of the studies about enhancing motor recovery in stroke 
patients) is not the optimal one. Moreover, it seems evident that the 
“compensatory/vicariation” model has good potentialities when applied to 
the theories about motor recovery mechanisms. 
It should be considered that an important factor that could 
influence the choice of NIBS technique boosting the effects of physical 
therapy and the theoretical model more suitable to obtain a better motor 
recovery is represented by post-stroke phase in which we are acting 
(acute vs chronic).  
Further, larger cohorts’ studies are warranted to better define this 




Motor deficit after a brain lesion, nowadays, represents the most 
frequent cause for disability in the world. Physical therapy, even was 
proven to be effective in recovery, is not sufficient to reach a 
satisfactorily level of quality of life after a stroke. For these reasons, 
neuromodulation was advocated as a potentially useful tool to boost the 
after-effects of physiotherapy: unfortunately the data from studies in 
which neuromodulation was paired to physical therapy didn’t show yet 
conclusive results. 
Here, when all the papers included in this compendium were 
evaluated at a glance, it jumps to attention that: 
1. Similar neuromodulation protocols are characterized by concrete 
subtle differences in the underlying mechanisms of action that 
could affect the choice in the application of one protocol instead of 
another one; patients that seem not to beneficiate from a 
neuromodulation protocol could beneficiate from another one 
(paper 1). 
2. Short latency afferent inhibition (studied in the early phase after a 
stroke) could differentiate between patients prone to better 
recovery and those who not, directing the single patients towards 




3. Particular attention should be paid on the functional role of the 
excitability and plasticity changes that occur after a stroke in each 
patient: it could be that, in general, the inter-hemispheric 
competition model was not always the optimal option as 
demonstrated in the acute stroke patients in paper 3. 
4. Changing the strategy of neuromodulation application, from inter-
hemisperic competition/rivalry model to compensatory/vicariation 
model could effectively enhance the after-effects of physical 
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